The QualityStocks Daily Stock List
- Aptevo Therapeutics (APVO)
- Marin Software (MRIN)
- Nine Energy Service (NINE)
- Mativ Holdings (MATV)
- Cresco Labs Inc. (CRLBF)
- NanoViricides, Inc. (NNVC)
- Red Cat Holdings (RCAT)
- GivBux (GBUX)
- Psyence Biomed (PBM)
- Quantum BioPharma (QNTM)
- Authentic Holdings (AHRO)
- Telomir Pharmaceuticals (TELO)
Aptevo Therapeutics (APVO)
QualityStocks, StockMarketWatch, MarketBeat, MarketClub Analysis, Premium Stock Alerts, TraderPower, StreetInsider, TradersPro, Early Bird, The Online Investor, InvestorPlace, Marketbeat.com, BUYINS.NET, Promotion Stock Secrets, Stock Beast and premiumstockalerts reported earlier on Aptevo Therapeutics (APVO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Aptevo Therapeutics Inc. (NASDAQ: APVO) (OTC: APVTW) (FRA: AP8N) is a clinical-stage biotechnology firm that is engaged in the development of immunotherapeutic candidates for treating different forms of cancer.
The firm has its headquarters in Seattle, Washington and was incorporated in 2016, on February 22nd. It operates as part of the pharmaceutical and medicine manufacturing industry, under the healthcare sector. The firm has three companies in its corporate family and serves consumers in the United States.
The company offers hematology and oncology therapeutics. It is party to an option and collabo-ration agreement with Alligator Biosciences AB, which entails the development of its ALG. APV-527 formulation.
The enterprise’s product pipeline comprises of a dual agonist bispecific antibody dubbed APVO603 which targets OX40 and CD137; and an investigational bispecific APAPTIR candi-date known as ALG.APV-527 which features a mechanism of action which targets CD137 and a tumor antigen expressed in different types of cancers known as 5T4. It also develops a bispecific candidate known as APVO442, which improves the bio-distribution of drugs to PSMA positive tumors for treating prostate cancer. In addition to this, the enterprise also develops a bispecific T-cell engaging antibody candidate dubbed APVO436, which is undergoing a phase 1 clinical trial evaluating its effectiveness in treating myelodysplastic syndrome and acute myelogenous leuke-mia.
Aptevo Therapeutics (APVO), closed Wednesday's trading session at $5.13, up 81.9149%, on 124,472,376 volume. The average volume for the last 3 months is 22,610 and the stock's 52-week low/high is $2.81/$485.366.
Marin Software (MRIN)
MarketClub Analysis, QualityStocks, StockMarketWatch, The Street, StreetInsider, Premium Stock Alerts, TradersPro, BUYINS.NET, Zacks, InvestorPlace, Marketbeat.com, PoliticsAndMyPortfolio, Schaeffer's, The Stock Dork, 360 Wall Street, Seeking Alpha, MarketBeat, Kiplinger Today, Street Insider, Insider Wealth Alert, INO.com Market Report, Daily Trade Alert and MarketWatch reported earlier on Marin Software (MRIN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Marin Software Inc. (NASDAQ: MRIN) (FRA: 2MAA) is a cloud-based digital advertising man-agement firm that is engaged in the provision of enterprise marketing software for agencies and advertisers in the UK and U.S., as well as internationally.
The firm has its headquarters in San Francisco, California and was incorporated in April 2006 by Wister Walcott, Joseph Chang, Paul M. Butler and Christopher A. Lien. It operates in the commu-nications sector, under the media industry, in the advertising and marketing sub-industry and offers its services to agencies and advertisers across the globe.
The enterprise’s objective is to give digital agencies and advertisers the power to optimize their paid marketing programs. It sells and markets its solutions to advertisers directly and via advertising agencies that utilize its platform on behalf of their consumers. The majority of the enterprise’s busi-ness activity is conducted within the geographical regions of the United States.
The company provides an ecommerce, search and social advertising platform dubbed MarinOne, which helps digital marketers make better decisions, win new consumers and convert precise audi-ences. This is in addition to providing Marin Social, which allows advertisers to manage their so-cial media account advertising on platforms like Twitter, Instagram and Facebook as well as Marin Search, which helps manage advertising campaigns for agencies and advertisers.
Marin Software (MRIN), closed Wednesday's trading session at $1.44, up 69.4118%, on 50,067,181 volume. The average volume for the last 3 months is 9,787,516 and the stock's 52-week low/high is $0.4085/$3.39.
Nine Energy Service (NINE)
MarketBeat, StreetInsider, MarketClub Analysis, QualityStocks, Zacks, Trading Concepts, InsiderTrades, StockMarketWatch, Wall Street Resources, TradersPro, OTCPicks, Streetwise Reports, InvestorPlace, SmarTrend Newsletters, BUYINS.NET, Marketbeat.com, OnTheMar, PennyTrader Publisher, Barchart, SmallCapVoice, Stock Stars, The Wealth Report, Trades Of The Day, TradeSmith Daily, WiseAlerts and Schaeffer's reported earlier on Nine Energy Service (NINE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Nine Energy Service (NINE)
Nine Energy Service Inc. (NYSE: NINE) (FRA: NEJ) is an onshore completion services provider which targets unconventional gas and oil resource development internationally.
The firm is based in Houston, Texas and was incorporated in 2011. Prior to its name change in Oc-tober the same year, the firm was known as NSC-Tripoint Inc. It operates as part of the oil and gas industry, under the energy sector, in the oil and gas services and equipment sub-industry. The firm has fifty-two companies in its corporate family and serves consumers across the globe.
The company operates through the production solutions and completion solutions segments. The former segment offers well workover and production enhancement services via ancillary equip-ment and well-servicing rigs while the latter segment provides completion tools, which include specialty open hole float equipment and centralizers, fully composite frac plugs, frac sleeves, liner hangers and accessories, as well as cementing services. The company operates in Canada and the U.S., among other countries, but generates most of its revenue from the U.S.
The enterprise, which also focuses on well solutions, provides wireline services consisting of plug-and-perf completions. It also provides coiled tubing services which include carrying out wellbore intervention operations through the use of a continuous steel pipe.
Nine Energy Service (NINE), closed Wednesday's trading session at $1.14, up 49.1951%, on 25,987,840 volume. The average volume for the last 3 months is 6,556,795 and the stock's 52-week low/high is $0.44/$2.02.
Mativ Holdings (MATV)
DividendStocks, MarketBeat, Zacks, Schaeffer's, InsiderTrades and Early Bird reported earlier on Mativ Holdings (MATV), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Mativ Holdings Inc. (NYSE: MATV) (FRA: MH2) is a company focused on manufacturing and selling specialty materials.
The firm has its headquarters in Alpharetta, Georgia and was incorporated in 1995, on August 21st. Prior to its name change it was referred to as Schweitzer-Mauduit International Inc. It oper-ates as part of the specialty chemicals industry, under the basic materials sector. Mativ Holdings serves consumers globally, with a focus on those in the United States, the Asia Pacific, Europe, and the Americas.
Mativ operates through the Filtration & Advanced Materials and the Sustainable & Adhesive So-lutions segments. The Filtration & Advanced Materials segment is involved in the manufacture and sale of a range of engineered polymer, resin and fiber-based substrates, nets, films, adhesive tapes, and other nonwovens for the filtration, industrial netting, and protective solutions end markets. On the other hand, the Sustainable & Adhesive Solutions segment provides tapes, la-bels, and liners that include substrates for tapes used in building and construction, infrastructure, DIY, athletic, and industrial application; and substrates critical to protection and adhesive separa-tion applications in the personal care, label, tape, industrial, graphic arts, composites, and medical categories, as well as performance labels and cable wrapping.
This segment also offers healthcare and other products, including wound care, consumer well-ness, device fixation, medical packaging; and paper and packaging products comprising premium printing and other specialty papers and packaging applications used for print collateral, advertis-ing, direct mail, sustainable alternatives, product packaging, graphics, and wallpaper. It serves tape, release liners, industrials, healthcare, and packaging and specialty papers end markets.
Mativ Holdings (MATV), closed Wednesday's trading session at $6.5, even for the day, on 346,277 volume. The average volume for the last 3 months is 659,125 and the stock's 52-week low/high is $4.34/$19.96.
Cresco Labs Inc. (CRLBF)
QualityStocks, CannabisNewsWire, InvestorPlace, Kiplinger Today, Daily Trade Alert, MarketBeat, Cabot Wealth, Top Pros' Top Picks, The Street, The Wealth Report, Wealth Insider Alert, Trading For Keeps, Trades Of The Day, The Online Investor, Early Bird, Prism MarketView, StreetInsider, wyatt research newsletter, TradersPro and StocksEarning reported earlier on Cresco Labs Inc. (CRLBF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
A new study on marijuana genetics reveals that the legal cannabis industry may be unintentionally reducing the plant’s genetic diversity. The push for faster-growing plants with higher cannabinoid content, mainly for economic and regulatory reasons, has led to a narrowing of the genetic pool.
The study, conducted by graduate student Caleb Y. Chen at California State Polytechnic University, Humboldt, draws from both genetic data and interviews with cannabis breeders. According to Chen, selective breeding practices in the current “post-prohibition” market are creating what he refers to as a genetic “bottleneck.”
While humans have always shaped cannabis genetics to suit their needs, recent breeding has focused narrowly on certain traits like high THC levels, a strong terpene profile, and consistency in chemical composition.
These choices may make sense in a market driven by regulation and consumer demand, but they come at a cost. In an earlier paper from 2021, Chen pointed out that many growers select high-THC strains not because they prefer them, but because state regulations and consumer expectations push them in that direction. As a result, genetic variation is being lost.
The issue isn’t exclusive to cannabis. Many crops face similar reductions in genetic variety due to selective breeding. However, cannabis seems especially vulnerable. The study highlights that what are often described as “wild” marijuana plants today are most likely just escaped domestic strains, not true wild varieties.
Natural processes like wind pollination can spread pollen from hybrid plants to local landrace strains, erasing their distinct genetic identities. This kind of contamination has been reported in countries like Thailand, Jamaica, India, and Mexico.
Chen warns that even without the history of prohibition, the cannabis plant is at risk of becoming genetically uniform. Today, only a small number of cultivars dominate the global market. These strains are treated much like other mass-produced crops, with little regard for preserving their genetic uniqueness.
He also points out that “craft marijuana,” while often used as a marketing label, represents a smaller, more diverse subculture within the industry. Some breeders and growers believe that current testing methods overlook certain compounds that contribute to the overall experience of using cannabis.
Chen’s research also touches on marketing practices, noting that commercial interests sometimes lead to misleading labels on cannabis strains. Growers may intentionally misname their products to meet consumer expectations or fit into regulatory categories.
The study concludes that modern cannabis regulations, falling product prices, and the push for higher yields are all contributing to reduced genetic diversity. It urges policymakers to recognize the importance of maintaining diverse cannabis genetics and recommends that breeders’ knowledge be taken seriously in future regulatory decisions.
It would be interesting to hear what major cannabis brands like Cresco Labs Inc. (CNX: CL) (OTCQX: CRLBF) think about concerns that marijuana genetic diversity is being sacrificed at the altar of commercial interests.
Cresco Labs Inc. (CRLBF), closed Wednesday's trading session at $0.48, up 1.3728%, on 502,577 volume. The average volume for the last 3 months is 95,860 and the stock's 52-week low/high is $0.4601/$2.05.
NanoViricides, Inc. (NNVC)
Tip.us, QualityStocks, MissionIR, SmallCapRelations, BioMedWire, SeriousTraders, InvestorBrandNetwork, Stocks to Buy Now, SmallCapSociety, NetworkNewsWire, StocksToBuyNow, Wall Street Resources, StockMarketWatch, TradersPro, Stock Preacher, InvestorSoup, Beacon Equity Research, PennyStocks24, MarketClub Analysis, BUYINS.NET, Jason Bond, StockProfessors, SuperStockTips, Penny Stocks Finder, StockHideout, MarketBeat, Penny Stock Craze, Stock Roach, SmarTrend Newsletters, StocksEarning, PennyStockShark, LightningStockPicks, Broad Street, The Daily Market Alert, Standout Stocks, Stock Analyzer, FeedBlitz, USA Market News, CoolPennyStocks, OTCPicks, Tiny Gems, Jeff Bishop, StreetAuthority Daily, PennyOmega, Smart Investing Society, HotOTC, TopStockAnalysts, Penny Stock Finder, ProTrader, uniquetokens, Market Wrap Daily, Small Caps, InvestorPlace, InvestorsUnderground, The Online Investor, HotStockChat, The Street, Greenbackers, Financial Newsletter, DrStockPick, CRWEPicks, CRWEFinance, BullRally, BestOtc, AllPennyStocks, All about trends, Agora Financial, CRWEWallStreet, StockEgg, SmallCapVoice, Stock Beast, Round Up the Bulls, RedChip, Real Pennies, Stock Market Watch, ProfitableTrading, PennyTrader Publisher, Zacks, Stock Rich, MarketClub, Stock Source, StreetInsider, Penny Pick Finders, Penny Invest, OTCReporter, StockHotTips, Stockwire, MicrocapVoice, MicroCapDaily, MegaPennyStocks, MarketMovingTrends, PennyToBuck and 360 Wall Street reported earlier on NanoViricides, Inc. (NNVC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
NanoViricides, Inc. (NYSE American: NNVC) asserts that its antiviral candidate NV-387 is uniquely positioned to address rising global threats from emerging COVID-19 variants like NB1.8.1 “Nimbus” and evolving strains of Bird Flu, including highly pathogenic genotypes identified in the U.S. and Cambodia. NV-387, which has completed Phase I trials without adverse events, is designed as an oral, broad-spectrum antiviral that mimics heparan sulfate structures—an invariant viral binding mechanism—making viral escape unlikely. The company reports NV-387 significantly outperformed leading antivirals like Remdesivir, Tamiflu(R), and Xofluza in animal models of lethal lung infections. NanoViricides emphasized its U.S.-based cGMP manufacturing readiness and ability to stockpile the drug, noting NV-387’s potential to deliver rapid patient recovery and natural immunity while avoiding the limitations of vaccine-dependent strategies.
To view the full press release, visit https://ibn.fm/QOvWs
About NanoViricides Inc.
NanoViricides is a development-stage company that is creating special purpose nanomaterials for antiviral therapy. The company’s novel nanoviricide(TM) class of drug candidates and the nanoviricide(TM) technology are based on intellectual property, technology and proprietary know-how of TheraCour Pharma, Inc. The company has a Memorandum of Understanding with TheraCour for the development of drugs based on these technologies for all antiviral infections. The MoU does not include cancer and similar diseases that may have viral origin but require different kinds of treatments. The company has obtained broad, exclusive, sub-licensable, field licenses to drugs developed in several licensed fields from TheraCour Pharma, Inc. The company’s business model is based on licensing technology from TheraCour Pharma Inc. for specific application verticals of specific viruses, as established at its foundation in 2005. NanoViricides’ lead drug candidate is NV-387, a broad-spectrum antiviral drug that the company plans to develop as a treatment of RSV, COVID-19, Long COVID, influenza, and other respiratory viral infections, as well as MPOX/Smallpox infections. The company is currently focused on advancing NV-387 into Phase II human clinical trials. NanoViricides’ other advanced candidate is NV-HHV-1 for the treatment of Shingles. The company cannot project an exact date for filing an IND for any of its drugs because of dependence on a number of external collaborators and consultants. NV-CoV-2 (“API NV-387”) is the company’s nanoviricide drug candidate for COVID-19 that does not encapsulate remdesivir. NV-CoV-2-R is NanoViricides’ other drug candidate for COVID-19 that is made up of NV-387 with remdesivir encapsulated within its polymeric micelles. For more information about the company, visit www.NanoViricides.com .
NanoViricides, Inc. (NNVC), closed Wednesday's trading session at $1.34, even for the day, on 121,893 volume. The average volume for the last 3 months is 12,351,720 and the stock's 52-week low/high is $0.94/$2.55.
Red Cat Holdings (RCAT)
QualityStocks, RedChip, TradersPro, Schaeffer's, StockEarnings, MarketClub Analysis, MarketBeat, Timothy Sykes, Zacks, Trades Of The Day, The Street, Premium Stock Alerts, InsiderTrades and 360 Wall Street reported earlier on Red Cat Holdings (RCAT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Red Cat Holdings (NASDAQ: RCAT) , a drone technology company integrating robotic hardware and software for military, government, and commercial operations, has announced its entry into securities purchase agreements with certain institutional investors for the purchase and sale of 6,448,276 shares of common stock, pursuant to a registered direct offering. The company anticipates gross proceeds of approximately $46.75 million from the offering, which, subject to the satisfaction of customary conditions, is expected to close on or about June 18, 2025. Red Cat intends to use net proceeds for general corporate and working capital purposes, including but not limited to operating expenditures related to its new unmanned surface vessel division. Northland Capital Markets is acting as the exclusive placement agent for the transaction.
To view the full press release, visit https://ibn.fm/wZwIy
About Red Cat Holdings Inc.
Red Cat is a drone technology company integrating robotic hardware and software for military, government, and commercial operations. Through two wholly owned subsidiaries, Teal Drones and FlightWave Aerospace, Red Cat has developed a leading-edge Family of Systems. This includes the flagship Black Widow(TM), a small unmanned ISR system that was awarded the U.S. Army’s Short Range Reconnaissance (“SRR”) Program of Record contract. The Family of Systems also includes TRICHON(TM), a fixed wing VTOL for extended endurance and range, and FANG(TM), the industry’s first line of NDAA compliant FPV drones optimized for military operations with precision strike capabilities. Learn more at www.redcat.red .
Red Cat Holdings (RCAT), closed Wednesday's trading session at $7.295, off by 0.3415301%, on 14,153,766 volume. The average volume for the last 3 months is 212,143,639 and the stock's 52-week low/high is $1/$15.2737.
GivBux (GBUX)
QualityStocks, TechMediaWire, SmallCapRelations, SeriousTraders, MissionIR, InvestorBrandNetwork, Stocks to Buy Now, Tip.us, StocksToBuyNow, SmallCapSociety, NetworkNewsWire and OTC Stock Review reported earlier on GivBux (GBUX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
GivBux (OTC: GBUX) , a publicly traded Super App and charitable giving platform, announced it has finalized a Share Exchange Agreement to acquire 100% of Charter House Financial AU, with the transaction set to close by July 13, 2025. The acquisition marks a shift in GivBux’s strategic focus toward gold-backed financial services, leveraging Charter House’s asset-backed infrastructure and global networks. The companies plan to integrate operations and jointly develop offerings that fuse precious metals with digital payments through the GivBux app. Charter House founder Anthony Capazze, a 25-year veteran in gold markets and finance, projected potential revenue of up to $200 million in the venture’s first full year. As part of the strategic shift, GivBux has also canceled previously announced deals, including a $39 million acquisition of VitorganAmerica.shop and a separate strategic investment, citing due diligence and funding issues.
To view the full press release, visit https://ibn.fm/LPcfz
About GivBux Inc.
The GivBux Super App revolutionizes shopping by offering a user-friendly tool to make purchases swiftly and easily at more than 100 national retailers, along with an expanding roster of local merchants. Users earn cash back on every purchase, a portion of which can be directed toward a charity of their choice, embodying GivBux’s commitment to “give back.” The GivBux Super App is free to use and available now. The GivBux Super App is constantly evolving and adding new enhancements and functionalities, including social networking, e-commerce, banking, messaging, food delivery and transportation. GivBux is forging a new path in e-commerce and charitable giving and aspires to build the largest community of givers, initially in the United States and eventually worldwide. To learn more about the company, visit www.GivBux.com .
GivBux (GBUX), closed Wednesday's trading session at $1.97, up 5.914%, on 102,354 volume. The average volume for the last 3 months is 10,491,448 and the stock's 52-week low/high is $0.2001/$10.05.
Psyence Biomed (PBM)
Premium Stock Alerts, Streetwise Reports, Top Pros' Top Picks, The Online Investor, The Daily Market Alert, StreetInsider, QualityStocks and MarketClub Analysis reported earlier on Psyence Biomed (PBM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Psyence Biomed (NASDAQ: PBM) has announced that its Chief of Global Impact, Mary-Elizabeth Gifford, was selected as a featured speaker at Psychedelic Science 2025 (“PS2025”) – the world’s largest international gathering focused on psychedelic research, biopharma, medicine, policy, and culture. Hosted by the Multidisciplinary Association for Psychedelic Studies (“MAPS”), the highly anticipated conference is taking place June 16-20, 2025, in Denver, Colorado. Psyence BioMed will present on business ethics in a panel session, “We are the Guardrails: Profit with Purpose.” In the role of Chief of Global Impact for Psyence Biomed, the first Nasdaq-listed biopharma with a focus on developing nature-derived (non-synthetic) psilocybin medicine for FDA approval, Gifford works in Washington, DC, to build bridges between research, regulation, and patient care.
To view the full press release, visit https://ibn.fm/qr93E
About Psyence Biomedical Ltd.
Psyence Biomed is one of the few multi-asset, vertically integrated biopharmaceutical companies specializing in psychedelic-based therapeutics. It is the first life sciences biotechnology company focused on developing nature-derived (non-synthetic) psilocybin and ibogaine-based psychedelic medicine to be listed on Nasdaq. The company is dedicated to addressing unmet mental health needs, particularly in palliative care. The name “Psyence” merges “psychedelics” and “science,” reflecting the company’s commitment to an evidence-based approach in developing safe, effective, and FDA-approved nature-derived psychedelic treatments for a broad range of mental health disorders. For more information, visit the company’s website at www.PsyenceBiomed.com .
Psyence Biomed (PBM), closed Wednesday's trading session at $4.92, off by 3.3399%, on 150,118 volume. The average volume for the last 3 months is 175,562 and the stock's 52-week low/high is $2.9218/$699.1882.
Quantum BioPharma (QNTM)
QualityStocks, SmallCapRelations, BioMedWire, InvestorBrandNetwork, MissionIR, SeriousTraders, Stocks to Buy Now, TechMediaWire, Tiny Gems, StocksToBuyNow, Tip.Us, NetworkNewsWire, TinyGems, SmallCapSociety, StockWireNews, Fierce Analyst, 360 Wall Street, Premium Stock Alerts and Timothy Sykes reported earlier on Quantum BioPharma (QNTM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Quantum BioPharma (NASDAQ: QNTM) continues to advance its pipeline targeting brain disorders and alcohol health, with Singular Research highlighting new clinical milestones and strategic updates. The company secured human ethics approval for a Phase 2 trial of FSD202 in patients with Idiopathic Mast Cell Activation Syndrome, marking progress in addressing unmet needs in inflammatory pain. Meanwhile, Quantum is preparing an IND filing for its Lucid-MS compound aimed at progressive Multiple Sclerosis and has launched a PET imaging study with Massachusetts General Hospital. Subsidiary Unbuzzd Wellness, focused on alcohol metabolism solutions, is preparing for a potential IPO, while Quantum also expanded its Bitcoin holdings to $5 million and plans to issue Contingent Value Rights linked to pending litigation. The company reported reduced administrative costs and increased R&D spend in Q1 2025, maintaining cash runway into 2027.
To view the full press release, visit https://ibn.fm/2jBYJ
About Quantum BioPharma Ltd.
Quantum BioPharma is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (“Lucid”), Quantum BioPharma is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. Quantum BioPharma invented UNBUZZD(TM) and spun out its OTC version to a company, Celly Nutrition Corp. (“Celly Nutrition”), led by industry veterans. Quantum BioPharma retains ownership of 25.71% (as of June 30, 2024) of Celly Nutrition at www.unbuzzd.com . The agreement with Celly Nutrition also includes royalty payments of 7% of sales from unbuzzd(TM) until payments to Quantum BioPharma total $250 million. Once $250 million is reached, the royalty drops to 3% in perpetuity. Quantum BioPharma retains 100% of the rights to develop similar products or alternative formulations specifically for pharmaceutical and medical uses. Quantum BioPharma maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.
Quantum BioPharma (QNTM), closed Wednesday's trading session at $30.18, up 17.295%, on 648,831 volume. The average volume for the last 3 months is 322,930 and the stock's 52-week low/high is $2.7/$31.6.
Authentic Holdings (AHRO)
QualityStocks, Stock Guru, SmallCap Network, FeedBlitz, MarketClub Analysis, RedChip, Bold Stocks, OTCReporter, Bull Trends, HotOTCBuzz.com, HotOTCChina.com, HotOTCPicks.com, HotPennyInvest.com, Juicy Penny Stocks, JumpingPennyStocks.com, OTCPennyPicks.com, UltimatePennyStock, SmartPennyInvest.com, Stock Twiter, StockGuru, Streetwise Reports, TooNiceStocks and OTCNewsAlerts.com reported earlier on Authentic Holdings (AHRO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Authentic Holdings (OTC: AHRO) announced a major licensing agreement between its subsidiary Maybacks Global Entertainment, LLC and Swerve TV, marked by a successful debut broadcast of “Ring of Combat” from the Tropicana in Atlantic City on June 13. The event exceeded expectations, drawing substantial viewership and social media traction across Swerve TV’s extensive platform, which reaches 80% of U.S. and Canadian households and over 5 million combat sports fans. The collaboration showcased the legacy of “Ring of Combat,” a promotion known for launching 165 fighters into the UFC, including champions like Matt Serra and Merab Dvalishvili. The broadcast success has laid the groundwork for future events and will be available on demand through the upcoming iDreamCTV app.
To view the full press release, visit https://ibn.fm/Rf7qP
About Authentic Holdings
Authentic Holdings combines entertainment, technology, and textiles to create a diverse portfolio of offerings. Their subsidiary Maybacks Global’s collaboration with WiseDV underscores their commitment to innovation in the streaming industry.
For more information, visit the company’s website at https://authenticholdingsinc.com/
Authentic Holdings (AHRO), closed Wednesday's trading session at $0.0016, even for the day, on 3,205,535 volume. The average volume for the last 3 months is 1,179,957 and the stock's 52-week low/high is $0.0003/$0.003.
Telomir Pharmaceuticals (TELO)
SmallCapRelations, SeriousTraders, QualityStocks, MissionIR, InvestorBrandNetwork, BioMedWire, Stocks to Buy Now, Tip.Us, StocksToBuyNow, SmallCapSociety, NetworkNewsWire and Prism MarketView reported earlier on Telomir Pharmaceuticals (TELO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Telomir Pharmaceuticals (NASDAQ: TELO) announced new preclinical data demonstrating that its lead candidate, Telomir-1, prevented cellular aging in human progeria cell lines obtained from the Progeria Research Foundation. In studies conducted by Smart Assays, Telomir-1 improved cell viability, reduced oxidative stress, and restored mitochondrial function in cells from a child with Hutchinson-Gilford Progeria Syndrome (HGPS), an ultra-rare pediatric aging disorder. Unlike the only FDA-approved treatment, which modestly extends lifespan without reversing disease pathology, Telomir-1 targets key mechanisms of progeria at the molecular level. The results build on previous animal studies and mark a significant step as the company advances IND-enabling work and prepares for potential orphan drug designation.
To view the full press release, visit https://ibn.fm/nCDp8
About Telomir Pharmaceuticals
Telomir Pharmaceuticals is a preclinical stage pharmaceutical company seeking to lead development in longevity science in both humans and animals. The company is focused on the development of Telomir-1, a novel small molecule designed to lengthen the DNA’s protective telomere caps, which are crucial in the aging process. Telomeres are the protective end caps of a chromosome made up of DNA sequences and proteins. As humans age, telomeres shorten, with metal reactivity accelerating the process, which presents humans and pet animals with an increased chance of contracting a number of degenerative and age-related diseases. Telomir’s goal is to develop, gain regulatory approval for and commercialize Telomir-1, proposed to be dosed orally, with the broader aim of promoting longevity and enhancing overall quality of life. For more information about the company, visit the website www.Telodx.com.
Telomir Pharmaceuticals (TELO), closed Wednesday's trading session at $1.76, off by 5.3763%, on 187,665 volume. The average volume for the last 3 months is 309,999 and the stock's 52-week low/high is $1.705/$8.4.
The QualityStocks Company Corner
- D-Wave Quantum Inc. (NYSE: QBTS)
- Nutriband Inc. (NASDAQ: NTRB)
- SolarBank Corp. (Cboe CA: SUNN) (FSE: GY2) (NASDAQ: SUUN)
- HeartBeam Inc. (NASDAQ: BEAT)
- Newton Golf Company Inc. (NASDAQ: NWTG)
- Platinum Group Metals Ltd. (TSX: PTM) (NYSE American: PLG)
- Solowin Holdings (NASDAQ: SWIN)
- Intelligent Bio Solutions Inc. (NASDAQ: INBS)
- Soligenix Inc. (NASDAQ: SNGX)
- Mullen Automotive Inc. (NASDAQ: MULN)
- Onar Holding Corporation (OTCQB: ONAR)
- Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF)
D-Wave Quantum Inc. (NYSE: QBTS)
The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).
D-Wave Quantum Inc. (NYSE: QBTS) ("D-Wave"), a leader in quantum computing systems, software, and services, announced that it has signed a memorandum of understanding (MOU) with Yonsei University and Incheon Metropolitan City aimed at accelerating quantum computing adoption in South Korea. Supporting the region's ambition to become a global quantum technology hub, the MOU outlines plans to work together on research, talent development, and use case exploration across biotechnology, materials science and other sectors. The MOU also facilitates the organizations' collaborative efforts towards the acquisition of a D-Wave Advantage2quantum system at the Yonsei University International Campus in Songdo, Yeonsu-gu, Incheon.
To view the full press release, visit https://ibn.fm/3ezs2
D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.
D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).
D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.
D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.
Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.
Advantage™ Quantum Computer
With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.
D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.
That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.
Leap Quantum Cloud Service
D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.
Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.
Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.
D-Wave Launch
D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.
From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.
Target Verticals
While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:
- Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
- Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
- Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.
Market Opportunity
The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.
Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.
D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.
D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.
Leadership Team
Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.
John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.
D-Wave Quantum Inc. (NYSE: QBTS), closed Wednesday's trading session at $15.71, up 1.0289%, on 785,978 volume. The average volume for the last 3 months is 97,674,137 and the stock's 52-week low/high is $0.7505/$19.765.
Recent News
- D-Wave Quantum Inc. (NYSE: QBTS) - TechMediaBreaks - D-Wave Quantum Inc. (NYSE: QBTS) Signs MOU to Advance Quantum Computing in South Korea
- Unpacking ChatGPT's Recent Outage
- The Open-Source Approach is Accelerating AI Innovation
Nutriband Inc. (NASDAQ: NTRB)
The QualityStocks Daily Newsletter would like to spotlight Nutriband Inc. (NASDAQ: NTRB).
Nutriband (NASDAQ: NTRB) , a developer of prescription transdermal pharmaceutical products, announced the successful commercial manufacturing process scale-up of its lead product, Aversa Fentanyl, in collaboration with Kindeva, a global CDMO specializing in drug-device combinations. Aversa Fentanyl integrates Nutriband's AVERSA abuse-deterrent technology with Kindeva's FDA-approved fentanyl patch and is produced at Kindeva's U.S.-based transdermal facility. The next step involves producing clinical supplies and submitting an Investigational New Drug application to begin a human abuse liability study. Nutriband projects Aversa Fentanyl, which aims to be the world's first abuse-deterrent opioid patch, could achieve peak U.S. sales between $80 million and $200 million, with broader global market ambitions supported by its extensive international patent portfolio.
To view the full article, visit https://ibn.fm/EJwVT
Nutriband Inc. (NASDAQ: NTRB) is engaged in the development of a portfolio of transdermal pharmaceutical products. The company’s AVERSA™ technology can be incorporated into any transdermal patch and includes aversive agents to prevent abuse, diversion, misuse and accidental exposure to drugs with abuse potential, specifically opioids.
AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, such as fentanyl, while making sure that these drugs remain accessible to patients who need them. The technology is covered by a broad intellectual property portfolio with patents granted in the United States, Europe, Japan, Korea, Russia, Canada, Mexico, Australia, and China, with recent extensions into Macao.
The company’s business model is to apply its transdermal technology to existing FDA-approved drugs with a goal of improving safety, efficacy and patient comfort while qualifying for a limited-development regulatory pathway that reduces the number of clinical trials required for approval of new drugs.
Nutriband has three subsidiaries, including 4P Therapeutics, its clinical and regulatory subsidiary; Pocono Pharmaceutical, a contract manufacturer for a wide range of clients; and Active Intelligence, a developer of sports recovery products. This ownership of manufacturing and clinical development capabilities drastically reduces costs for AVERSA and other technologies.
In April 2024, Nutriband announced that the company had been engaged by and received a first order from Fit For Life Group, a major brand license holder. A fully executed supplier agreement is expected to follow. Nutriband’s wholly owned Active Intelligence subsidiary will act as manufacturer.
In February 2025, the company formalized its product development partnership with Kindeva Drug Delivery through a long-term exclusive agreement. The collaboration supports the commercial pathway for AVERSA Fentanyl by leveraging Kindeva’s FDA-approved transdermal fentanyl patch system.
The company is headquartered in Orlando, Florida.
Products
Nutriband’s lead product candidate is AVERSA Fentanyl, an abuse-deterrent fentanyl transdermal patch. The company announced in March 2024 that it will submit a New Drug Application to the U.S. Food and Drug Administration seeking approval to market AVERSA Fentanyl. In subsequent updates, Nutriband confirmed that the NDA submission remains the company’s primary focus and is backed by a strong cash position.
Nutriband has partnered with Kindeva Drug Delivery, a leading global contract development and manufacturing organization, to incorporate Nutriband’s AVERSA abuse-deterrent transdermal technology into Kindeva’s FDA-approved transdermal fentanyl patch system. Because Nutriband’s abuse-deterrent technology is incorporated into the fentanyl patch but is physically separate from and does not come in contact with the drug layer, the clinical trials typically needed to demonstrate safety and efficacy for a new drug formulation would not be required.
In support of this commercialization strategy, Nutriband closed an $8.4 million private placement in April 2024 to fund development activities related to AVERSA Fentanyl. The company also licensed Bitrex®, a widely used aversive agent, to enhance the deterrent profile of its patch formulation.
AVERSA Fentanyl has the potential to be the first and only abuse deterrent patch approved anywhere in the world. The company plans to seek an expedited review by the FDA, as has been granted for certain abuse-deterrent oral opioid products, which shortens the regulatory review period to six months from the conventional 10-month FDA review cycle for NDAs.
Nutriband’s AVERSA product development pipeline also includes abuse deterrent versions of currently approved and marketed transdermal patches containing buprenorphine, an opioid used to treat opioid use disorder, and methylphenidate, a central nervous system stimulant used in the treatment of attention deficit hyperactivity disorder (ADHD). Both are labeled with FDA-required warnings for the risk of abuse and misuse, as well as warnings against accidental exposure.
Market Opportunity
Nutriband cites a market analysis report from Boston-based Health Advances, a healthcare and life sciences consulting firm. According to the report, upon FDA approval, AVERSA Fentanyl has the potential to reach peak annual sales of $200 million in the U.S.
The company further states that, should non-abuse-deterrent transdermal fentanyl products lose FDA marketing approval, AVERSA Fentanyl would have greater pricing flexibility and would have the potential to generate more than $500 million in annual revenue.
Management Team
Gareth Sheridan is Co-Founder and CEO of Nutriband. He was Ireland’s ‘Young Entrepreneur of the Year’ in 2014 for establishing Nutriband. He has worked as a Business Mentor with 100 Minds, a social enterprise that brings together some of Ireland’s top college students and connects them with a cause to achieve large charitable goals. He received a B.Sc. in Business and Management from Dublin Institute of Technology.
Serguei Melnik is Co-Founder and President of Nutriband. He has been involved in general business consulting for companies in the U.S. financial markets and setting up legal and financial frameworks for operations of foreign companies in the U.S. He previously was the COO of Florida-based Asconi Corporation. He also was a lawyer in the Department of Foreign Affairs, JSC Bank “Inteprinzbanca,” in Chisinau, Moldova, and prior to that practiced law in Moldova. He is fluent in four languages.
Jeff Patrick, Pharm.D., is Chief Scientific Officer of Nutriband. He currently serves as Director of the Drug Development Institute at the Ohio State University Comprehensive Cancer Center. His prior roles included Global Vice President at Mallinckrodt Pharmaceuticals Inc.; and roles at Dyax, Myogen/Gilead, Actelion and Sanofi-Synthelabo Inc. He was a clinical pharmacist at the University of Tennessee Medical Center and a clinical assistant professor of pharmacy at the University of Tennessee College of Pharmacy.
Gerald Goodman is CFO of Nutriband. He is a certified public accountant with his own firm, Gerald Goodman CPA. He also practiced with Madsen & Associates, CPAs, and was a partner in the accounting firm of Wiener, Goodman & Company. He is also a director of Lifestyle Medical Network Inc., which provides management services to healthcare providers. He is a graduate of Pennsylvania State University, where he received a bachelor’s degree in accounting.
Investment Considerations
- Nutriband’s AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, like fentanyl, while keeping these drugs accessible to patients.
- AVERSA technology can be incorporated into any transdermal patch.
- The company has a broad and expanding intellectual property portfolio protecting AVERSA, with patents granted in the U.S., Europe, Japan, Korea, Russia, Canada, Mexico, Australia, and China.
- Nutriband closed an $8.4 million financing round in April 2024 to support commercial development of AVERSA Fentanyl, its abuse-deterrent fentanyl transdermal patch.
- In February 2025, the company formalized a long-term exclusive partnership with Kindeva Drug Delivery to support AVERSA Fentanyl’s pathway to market.
Additional Resources
Nutriband Inc. (NASDAQ: NTRB), closed Wednesday's trading session at $7.79, up 0.516129%, on 6 volume. The average volume for the last 3 months is 67,356 and the stock's 52-week low/high is $3.7223/$11.78.
Recent News
- Nutriband Inc. (NASDAQ: NTRB) - BioMedNewsBreaks - Nutriband Inc. (NASDAQ: NTRB) Advances Aversa Fentanyl with Kindeva to Commercial Manufacturing Scale
- Nutriband Inc. (NASDAQ: NTRB) Reports Double-Digit Revenue Increase, Continued Progress on AVERSA Fentanyl Development
- BioMedNewsBreaks - Nutriband Inc. (NASDAQ: NTRB) Secures U.S. Patent for Abuse-Deterrent Transdermal Technology
SolarBank Corp. (Cboe CA: SUNN) (FSE: GY2) (NASDAQ: SUUN)
The QualityStocks Daily Newsletter would like to spotlight SolarBank Corp. (Cboe CA: SUNN) (FSE: GY2) (NASDAQ: SUUN).
SolarBank Corporation joins a group of 61 public companies adopting bitcoin treasury strategies.
The company expects to bridge growing investor interest in crypto with the stability of renewable energy.
SolarBank has applied to open an account with Coinbase Prime for custody and related services.
CEO Richard Lu says the strategy helps attract a new class of tech-savvy investors.
Disseminated on behalf of SolarBank Corporation
SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) , a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., announced this month it will begin holding bitcoin as part of its treasury reserves. The strategy marks SolarBank as one of the early adopters of what is becoming an increasingly common approach among publicly traded firms looking to diversify assets and attract new investors.
California is moving quickly to build one of the biggest clean energy projects ever. The state's Energy Commission has given the green light to the Darden Clean Energy Project, which will be the largest battery energy storage system in the world. It's also the first project to get fast-track approval through a new state program called the Opt-In Certification Program created to help California switch fully to clean energy by 2045. The Darden Project will bring together solar power and battery storage on a huge scale. It will use about three million solar panels to produce 1.1 gigawatts of solar energy. The power will be stored in a massive 4,600 megawatt (MW) battery system, which can supply electricity to around 850,000 households for about four hours, ideal for times when the sun goes down or energy demand is high. Even with these concerns, battery storage is expanding quickly. In 2023, the U.S. saw a 98% boost in new grid-scale battery installations. California leads the nation with over 200 large systems and more than 250,000 small ones. Gov. Gavin Newsom called the Darden Project a major win for clean energy, jobs, and local communities, marking a bold step toward a reliable, green power future. This rapidly-expanding market for BESS facilities strongly suggests that other industry players, such as SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) have a huge potential market to serve over the coming decades if they position themselves appropriately in the markets showing the greatest potential.
SolarBank Corporation (NASDAQ: SUUN) (CSE: SUNN) is a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the United States. The company is committed to advancing the transition to sustainable energy by offering end-to-end services that include project origination, financing structuring, engineering, procurement, construction, and long-term operations and maintenance. SolarBank focuses on delivering innovative energy solutions through solar photovoltaic systems, battery energy storage systems (BESS), and electric vehicle (EV) charging infrastructure.
With a vision to provide scalable and reliable clean energy solutions, SolarBank has established itself as a leader in the renewable energy market by cultivating partnerships with utilities, commercial and industrial entities, municipalities, and residential customers. Its vertically integrated business model allows for optimized efficiency, cost management, and returns across diverse markets in North America. This end-to-end approach ensures greater control over project quality, costs, and operational outcomes, strengthening its competitive position.
Driven by a mission to create a greener future, SolarBank manages a robust portfolio of projects, including more than 100 megawatts (MW) of developed capacity and a pipeline exceeding one gigawatt (GW). The company’s commitment to sustainability and innovation makes it a recognized player in the renewable energy sector.
SolarBank has offices in Toronto, Ontario and New York.
Projects
SolarBank boasts an impressive and diverse portfolio of renewable energy initiatives that underline its leadership in the clean energy space. In the U.S., the company has over 250 MW of solar projects under development, principally in New York, focusing on community solar farms and commercial and industrial installations. Notably, SolarBank is developing several community solar projects in upstate New York, which will deliver clean energy to local residents and small businesses. Community solar projects, which are a cornerstone of SolarBank’s portfolio, provide scalable solutions for renters, homeowners, and small businesses to access affordable renewable energy, driving localized energy independence and economic savings.
In Canada, SolarBank has been a significant participant in Ontario’s Feed-in-Tariff program, where it has secured contracts for close to 200 MW of capacity. Its current management includes 70 solar power projects, totaling 28.8 MW of operational solar assets. The company’s expertise extends to the development and ownership of battery energy storage systems and EV charging stations, further diversifying its portfolio.
The company’s vertically integrated approach spans the entire project lifecycle, from initial site acquisition and grid interconnection to long-term operation and maintenance services. This ensures seamless execution and high-quality outcomes, providing value to stakeholders and supporting the transition to a clean energy future.
Market Opportunity
SolarBank operates within a growing renewable energy market driven by global demand for sustainable power solutions. In North America, favorable policies such as the Inflation Reduction Act in the United States and Canada’s investments in green technologies provide a robust foundation for renewable energy adoption. Solar PV installations and battery energy storage systems are at the forefront of this expansion, addressing energy reliability and grid stability while reducing carbon emissions.
The North American solar PV market was valued at $25.02 billion in 2019 and is projected to reach $120.74 billion by 2027, growing at a compound annual growth rate (CAGR) of 21.7% from 2020 to 2027. Likewise, the global BESS market is expected to expand from $7.8 billion in 2024 to $25.6 billion by 2029, at a CAGR of 26.9%, as reported by MarketsandMarkets. These trends are driven by the increasing integration of renewable energy sources, the need for grid resilience, and declining technology costs.
SolarBank’s operations have it well-positioned to capitalize on these opportunities. With a development pipeline exceeding one gigawatt (GW), the company is focused on meeting growing demand in community and commercial solar sectors. Decentralized energy solutions, such as virtual net metering and behind-the-meter systems, further enhance SolarBank’s market potential by addressing the critical need for flexible, cost-effective, and sustainable energy infrastructure. By leveraging its vertically integrated model and diversified portfolio, SolarBank stands as a key player in driving the renewable energy transition.
Leadership Team
Dr. Richard Lu, MD, MSc., MHSc., MBA, serves as President and CEO of SolarBank, bringing over 25 years of global energy experience. His leadership has been instrumental in advancing the company’s strategic initiatives across North America, Europe, and Asia, with a focus on renewable energy development and operational excellence.
Sam Sun, MBA, is the Chief Financial Officer of SolarBank. A Chartered Professional Accountant with more than 15 years of expertise in corporate finance, Mr. Sun has overseen financial strategies and internal controls across the cleantech, manufacturing, and mining sectors in Canada, the U.S., and China.
Andrew van Doorn, PE, serves as Chief Operating Officer, with nearly three decades of experience in engineering and construction. Mr. van Doorn has successfully led projects totaling over 200 MW of solar capacity and is a former Chairman of the Canadian Solar Industries Association.
Tracy Zheng, MBA, Chief Development Officer, has over 25 years of experience in brand marketing, business development, and solar project operations. She has spearheaded sales initiatives, conducted feasibility studies, and negotiated key partnerships that drive SolarBank’s growth.
Matt Wayrynen, Executive Chairman and Director, has a background in resource company management, venture capital, and mergers and acquisitions. Under his leadership, Solar Flow-Through Funds, where Mr. Wayrynen acted as CEO, was acquired by SolarBank, enhancing its asset portfolio and growth prospects.
Forward Looking Statements
This report contains forward-looking statements and forward-looking information within the meaning of Canadian securities legislation (collectively, “forward-looking statements”) that relate to the Company’s current expectations and views of future events. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, through the use of words or phrases such as “will likely result”, “are expected to”, “expects”, “will continue”, “is anticipated”, “anticipates”, “believes”, “estimated”, “intends”, “plans”, “forecast”, ”projection”, “strategy”, “objective” and “outlook”) are not historical facts and may be forward-looking statements and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ materially from those expressed in such forward-looking statements. In particular and without limitation, this report contains forward-looking statements pertaining to the Company’s expectations regarding its industry trends and overall market growth of the data center market; the Company’s expansion into the data center market, including its pursuit of opportunities as a developer, owner, and strategic partner in data center infrastructure; supporting the demand for high-performance, sustainable energy solutions within the sector; details of the company’s business plan including development of solar power projects, battery storage projects and EV charging projects; the completion of any contracts for, or construction of, any data center, solar power, battery storage or EV projects; the receipt of interconnection approval, permits and financing to be able to construct projects; the receipt of incentives for projects; and the size of the Company’s development pipeline. No assurance can be given that these expectations will prove to be correct and such forward-looking statements included in this report should not be unduly relied upon. These statements speak only as of the date of this report.
Forward-looking statements are based on certain assumptions and analyses made by the Company in light of the experience and perception of historical trends, current conditions and expected future developments and other factors it believes are appropriate, and are subject to risks and uncertainties. In making the forward looking statements included in this report, the Company has made various material assumptions, including but not limited to: obtaining the necessary regulatory approvals; that regulatory requirements will be maintained; general business and economic conditions; the Company’s ability to successfully execute its plans and intentions; the availability of financing on reasonable terms; the Company’s ability to attract and retain skilled staff; market competition; the products and services offered by the Company’s competitors; that the Company’s current good relationships with its service providers and other third parties will be maintained; and government subsidies and funding for renewable energy will continue as currently contemplated. Although the Company believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect, and the Company cannot assure that actual results will be consistent with these forward-looking statements. Given these risks, uncertainties and assumptions, investors should not place undue reliance on these forward-looking statements.
Whether actual results, performance or achievements will conform to the Company’s expectations and predictions is subject to a number of known and unknown risks, uncertainties, assumptions and other factors, including those listed under “Forward-Looking Statements” and “Risk Factors” in the Company’s most recently completed Annual Information Form, and other public filings of the Company, which include: the Company may be adversely affected by volatile solar power market and industry conditions; the execution of the Company’s growth strategy depends upon the continued availability of third-party financing arrangements; the Company’s future success depends partly on its ability to expand the pipeline of its energy business in several key markets; governments may revise, reduce or eliminate incentives and policy support schemes for solar and battery storage power; general global economic conditions may have an adverse impact on our operating performance and results of operations; the Company’s project development and construction activities may not be successful; developing and operating solar projects exposes the Company to various risks; the Company faces a number of risks involving Power Purchase Agreements (“PPAs”) and project-level financing arrangements; any changes to the laws, regulations and policies that the Company is subject to may present technical, regulatory and economic barriers to the purchase and use of solar power; the markets in which the Company competes are highly competitive and evolving quickly; an anti-circumvention investigation could adversely affect the Company by potentially raising the prices of key supplies for the construction of solar power projects; foreign exchange rate fluctuations; a change in the Company’s effective tax rate can have a significant adverse impact on its business; seasonal variations in demand linked to construction cycles and weather conditions may influence the Company’s results of operations; the Company may be unable to generate sufficient cash flows or have access to external financing; the Company may incur substantial additional indebtedness in the future; the Company is subject to risks from supply chain issues; risks related to inflation; unexpected warranty expenses that may not be adequately covered by the Company’s insurance policies; if the Company is unable to attract and retain key personnel, it may not be able to compete effectively in the renewable energy market; there are a limited number of purchasers of utility-scale quantities of electricity; compliance with environmental laws and regulations can be expensive; corporate responsibility may adversely impose additional costs; the future impact of any resurgence of COVID-19 on the Company is unknown at this time; the Company has limited insurance coverage; the Company will be reliant on information technology systems and may be subject to damaging cyberattacks; the Company may become subject to litigation; there is no guarantee on how the Company will use its available funds; the Company will continue to sell securities for cash to fund operations, capital expansion, mergers and acquisitions that will dilute the current shareholders; and future dilution as a result of financings.
The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. New factors emerge from time to time, and it is not possible for the Company to predict all of them, or assess the impact of each such factor or the extent to which any factor, or combination of factors, may cause results to differ materially from those contained in any forward-looking statement. Any forward-looking statements contained in this report are expressly qualified in their entirety by this cautionary statement.
Additional Resources
SolarBank Corp. (NASDAQ: SUUN), closed Wednesday's trading session at $1.82, up 2.8249%, on 1,676 volume. The average volume for the last 3 months is 529,488 and the stock's 52-week low/high is $1.23/$6.65.
Recent News
- SolarBank Corp. (Cboe CA: SUNN) (FSE: GY2) (NASDAQ: SUUN) - California to Fast-Track Largest Project for Battery Energy Storage
- SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Among Early Adopters of Bitcoin Treasury Strategies Amid Growing Trend
- TechMediaBreaks - SolarBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Advances 2.4 MW Community Solar Project in Nova Scotia
HeartBeam Inc. (NASDAQ: BEAT)
The QualityStocks Daily Newsletter would like to spotlight HeartBeam Inc. (NASDAQ: BEAT).
HeartBeam (NASDAQ: BEAT), announced the issuance of two new U.S. patents that strengthen its intellectual property portfolio and support the company's expansion in remote cardiac diagnostics. The new patents protect core technologies behind HeartBeam's compact, cable-free 3D ECG device and its rhythm analysis algorithm capable of identifying arrhythmias through continuous signal input.
The 3D ECG device, which uses chest and finger electrodes to collect high-fidelity signals in three non-coplanar directions, is designed for on-demand symptom recording and 12-lead ECG synthesis. Its software is currently under FDA review, backed by data from the VALID-ECG pivotal study. The rhythm algorithm works across cardiac monitoring systems and triggers targeted data collection during abnormal rhythm detection, enhancing diagnostic precision.
With 20 issued patents and 34 additional filings, HeartBeam continues to solidify its position at the forefront of digital cardiac care innovation, with future plans to incorporate AI capabilities for enhanced diagnostic accuracy.
To view the full press release, visit https://ibn.fm/iJ35f
HeartBeam Inc. (NASDAQ: BEAT) is a medical technology company developing a groundbreaking solution for at-home detection and monitoring of cardiac conditions. The company is creating the first ever cable-free synthesized 12-lead ECG platform designed to give patients the ability to record their symptoms the moment they occur, wherever they are. By providing synthesized, 12-lead ECG data, physicians can quickly assess the symptoms and ensure patients get the care they need in a timely manner. It also eliminates the need for wires, complex setup, or clinical staff, thus allowing synthesized 12-lead ECG signals to be accessible outside of a medical setting.
HeartBeam’s vision is to redefine cardiac care by enabling early detection, proactive monitoring, and informed clinical decisions outside the confines of a traditional medical setting. Its patented approach not only delivers similar, but not identical, accuracy of conventional 12-lead ECGs for arrhythmia detection but also unlocks future capabilities in ischemia detection, AI-assisted analysis, and longitudinal cardiac trend tracking.
The HeartBeam System is now FDA cleared for arrhythmia assessment, following foundational 510(k) clearance granted in December 2024. The company submitted a 510(k) application for its 12-lead ECG synthesis software in January 2025 for arrhythmia assessment. As it approaches commercialization, HeartBeam is executing a multi-phase go-to-market strategy with initial U.S. rollout plans and a focus on high-margin, recurring revenue.
The company is headquartered in Santa Clara, California.
Products
HeartBeam’s flagship product is a credit card-sized, cable-free device designed to capture ECG signals in three non-coplanar directions and transform them into synthesized 12-lead ECGs. This novel form factor integrates a smartphone app, cloud connectivity, and a physician portal, enabling patients to record cardiac events at the moment symptoms occur and physicians to assess and triage in near real time.
The device is supported by an expanding software ecosystem. A key component of this is HeartBeam’s proprietary 12-lead ECG synthesis software, which met its clinical endpoint in the VALID-ECG pivotal study with 93.4% manual diagnostic agreement for arrhythmia assessment. This software is currently under FDA review and is designed to deliver clinical-grade arrhythmia diagnostic capabilities outside of traditional healthcare environments.
In April 2025, HeartBeam announced a strategic partnership with AccurKardia to incorporate its FDA-cleared ECG analysis software, AccurECG™, into HeartBeam’s offering. This integration is expected to enhance automated rhythm interpretation, streamline physician workflows, and improve diagnostic speed and accuracy.
Additional form factors are under development, including an on-demand synthesized 12-lead patch with issued patents, intended to serve the extended-wear market segment. These complementary offerings are intended to support chronic disease management and continuous monitoring applications, broadening HeartBeam’s total product ecosystem in the future.
Market Opportunity
HeartBeam is targeting large and growing segments within the $20 billion+ global cardiac monitoring and diagnostics market. According to the company’s own materials, the U.S. concierge care segment alone represents a $500 million serviceable addressable market (SAM), comprising approximately 1.5 million patients—500,000 of whom are at elevated cardiac risk. This initial focus provides a strategic entry point for cash-pay and early adoption.
Expanding beyond this niche, HeartBeam identifies a $1.3 billion to $2.6 billion annual opportunity in the broader U.S. direct patient pay market, driven by more than 2.6 million high-income individuals aged 35–74 with elevated cardiac risk. For comparison, more than 2.5 million Oura rings and over 3 million AliveCor Kardia devices have been sold, demonstrating strong consumer willingness to adopt personal cardiac technologies.
HeartBeam’s long-term opportunity is significantly larger. The company estimates that over 20 million people in the U.S. are at high risk for myocardial infarction (MI), representing a total addressable market nearly 40 times greater than the concierge segment. Additionally, the company’s on-demand 12-lead patch aims to capture market share in the extended wear and mobile cardiac telemetry (MCOT) space, competing with incumbents like iRhythm, Boston Scientific, Philips, and Baxter.
Leadership Team
Robert P. Eno, Chief Executive Officer and Director, brings over 30 years of experience launching disruptive medical technologies and leading commercialization efforts. He has held executive roles at HeartFlow, OptiMedica, NeoGuide Systems, and Avantec Vascular, and holds an MBA and BA from Stanford University.
Branislav Vajdic, PhD, President and Founder, is a seasoned innovator with over three decades of experience in technology and device development. He co-invented flash memory at Intel and led engineering teams responsible for the Pentium processor series. He previously served as CEO of NewCardio and holds a PhD in Electrical Engineering from the University of Minnesota.
Timothy Cruickshank, Chief Financial Officer, has over 15 years of experience in financial and strategic leadership roles. Formerly CFO at ImpediMed, he transformed the company into a SaaS-driven model. He holds an MBA from Keller Graduate School and a BS in Accounting from Syracuse University.
Peter J. Fitzgerald, MD, PhD, Chief Medical Officer, is a Stanford professor emeritus and interventional cardiologist with leadership in over 175 clinical trials and 24 medical startups. He co-founded TriVentures and has advised the FDA for over 20 years.
Ken Persen, Chief Technology Officer, has more than 25 years of experience in cardiac and digital health technology, including founding LIVMOR and leadership roles at Guidant and Cameron Health. He specializes in system design and product engineering for connected cardiac solutions.
Investment Considerations
- HeartBeam has developed the first cable-free system capable of synthesizing a 12-lead ECG from 3D, non-coplanar electrical signals captured in real time.
- Patients can have the HeartBeam System with them at all times, ready to record an ECG in 30 seconds at home or anywhere when they feel symptoms to reduce delays in care.
- The HeartBeam System is now FDA cleared for arrhythmia assessment, with additional FDA review underway for its 12-lead ECG synthesis software for the same indication.
- A recent partnership with AccurKardia enhances HeartBeam’s arrhythmia solution with an FDA-cleared automated rhythm interpretation software.
- HeartBeam holds 20 issued patents, with additional allowed and pending applications, protecting its proprietary hardware, software, and algorithmic capabilities.
- Commercial launch is expected to be imminent, targeting a $500 million concierge SAM and broader multibillion-dollar patient pay market, supported by a high-margin, recurring revenue model.
Additional Resources
HeartBeam Inc. (NASDAQ: BEAT), closed Wednesday's trading session at $1.58, up 1.9355%, on 110,405 volume. The average volume for the last 3 months is 125,608 and the stock's 52-week low/high is $1.45/$3.48.
Recent News
- HeartBeam Inc. (NASDAQ: BEAT) - InvestorNewsBreaks - HeartBeam Inc. (NASDAQ: BEAT) Secures Two New Patents Advancing 3D ECG and Cardiac Monitoring Technology
- BioMedNewsBreaks - HeartBeam Inc. (NASDAQ: BEAT) and AccurKardia Join Forces to Advance Remote Cardiac Monitoring
- BioMedNewsBreaks - HeartBeam Inc. (NASDAQ: BEAT) VALID-ECG Study Confirms Diagnostic Accuracy of Synthesized 12-Lead ECG
Newton Golf Company Inc. (NASDAQ: NWTG)
The QualityStocks Daily Newsletter would like to spotlight Newton Golf Company Inc. (NASDAQ: NWTG).
Newton Golf Company (NASDAQ: NWTG) , a technology-forward golf brand, announced that PGA TOUR Champions star Miguel Ángel Jiménez has officially joined the company and will play its Newton Fast Motion shaft, which he used to win the Principal Charity Classic. Jiménez's playoff win in Iowa marked his 16th PGA TOUR Champions title and the second Tour victory for Newton's Motion shaft line. The Fast Motion shaft, launched in April 2025, features advanced carbon fiber construction and proprietary performance technologies aimed at delivering speed, control, and consistency for golfers with moderate swing speeds. The win further validates Newton's impact across professional tours, following Doug Barron's 2024 major win at the Regions Tradition.
To view the full press release, visit https://ibn.fm/PuvqD
Newton Golf Company Inc. (NASDAQ: NWTG), a Sacks Parente Company, is a technology-forward golf equipment manufacturer committed to enhancing player performance through innovative design. Since its founding in 2018, the company has developed a growing portfolio of premium golf products, including putters, golf shafts, grips, and related accessories. Its proprietary advancements include the First Vernier Acuity putter, patented Ultra-Low Balance Point (ULBP) technology, weight-forward Center-of-Gravity (CG) design, and ultra-light carbon fiber putter shafts.
As part of its commitment to growth in golf shaft technologies, the company expanded its manufacturing operations in April 2022, opening a dedicated facility in St. Joseph, Missouri. This move reinforced its goal of maintaining high-quality production standards while manufacturing and assembling substantially all of its products in the United States. In addition to golf clubs and accessories, Newton Golf Company is exploring expansion into golf apparel and other product categories.
The company sells its products through multiple channels, including resellers, its direct-to-consumer website, Club Champion retail stores, and distributors in the U.S., Japan, and South Korea. Future expansion may include growth through mergers, acquisitions, or the development of complementary product lines.
Newton Golf Company is headquartered in Camarillo, California.
Products
Newton Golf Company is focused on delivering high-performance golf equipment with a strong emphasis on precision engineering and cutting-edge materials. The company’s key product lines include:
- Newton Motion Golf Shafts: Launched in November 2023, these shafts are engineered with proprietary flex profiles designed for greater distance, reduced dispersion, and optimized performance across swing speeds. The company’s DOT system eliminates traditional shaft flex definitions, making it accessible to all golfers.
- Gravity Putters: Introduced in October 2024, these putters incorporate patented Ultra-Low Balance Point (ULBP) technology to improve stroke consistency and tighten putt dispersion. Manufactured in the U.S., they feature premium materials such as steel, aluminum, titanium alloys, and patented magnesium face plate technology.
- Golf Grips & Accessories: The company continues to innovate in this category, providing golfers with performance-enhancing grips and accessories to complement their clubs.
All Newton Golf Company products are manufactured with strict quality control standards to ensure precision and reliability, reinforcing the brand’s reputation for premium performance.
Market Opportunity
The global golf equipment market was valued at approximately $8 billion in 2022, with the U.S. market accounting for $2.9 billion. The golf club segment dominated the industry, representing 45.7% of total market share. Increasing participation in golf, particularly among younger players and women, is driving demand for high-quality, customizable golf equipment.
Key industry trends supporting growth include:
- The increasing popularity of premium, high-performance golf equipment among both professionals and amateurs.
- A shift toward customization, as golfers seek tailored products that enhance performance.
- A growing interest in golf from younger demographics, with amateur and collegiate golfers being particularly receptive to innovation.
Newton Golf Company’s emphasis on U.S.-based manufacturing provides it with a competitive edge in terms of supply chain efficiency, quality control, and sustainability, further strengthening its position in the market.
Leadership Team
Dr. Greg Campbell, Executive Chairman and Chief Executive Officer, brings nearly 40 years of experience in emerging technologies, product development, and public company leadership. He currently serves as CEO of V-Grid Energy Systems, a California-based company focused on converting agricultural waste into renewable electricity and bio-carbon. He has successfully taken two companies public and previously managed a $1.2 billion P&L as SVP & GM at Lam Research. Campbell holds a Ph.D. in Electrical and Electronics Engineering from UCLA and a BA/MA in Engineering from Cambridge University.
Ryan Stearns, Chief Financial Officer, was appointed in 2024 and oversees financial planning and corporate strategy. He brings expertise in scaling businesses and optimizing financial performance to support the company’s growth.
Investment Considerations
- Newton Golf Company operates in a large and expanding global golf equipment market with rising demand for high-performance products.
- The company benefits from strong gross margins and a clear pathway to profitability as it scales its operations.
- U.S.-based manufacturing provides strict quality control, supply chain efficiency, and faster response times to market demand.
- An omnichannel sales strategy, including retail, e-commerce, and international distribution, enhances market reach and revenue diversification.
- Future growth opportunities include new product lines, strategic acquisitions, and continued technological advancements in golf equipment.
Additional Resources
Newton Golf Company Inc. (NASDAQ: NWTG), closed Wednesday's trading session at $1.57, up 1.2903%, on 397 volume. The average volume for the last 3 months is 195,013 and the stock's 52-week low/high is $1.35/$195.
Recent News
- Newton Golf Company Inc. (NASDAQ: NWTG) - InvestorNewsBreaks - Newton Golf Company Inc. (NASDAQ: NWTG) Signs Miguel Ángel Jiménez Following Victory with Fast Motion Shaft
- Newton Golf Company Inc. (NASDAQ: NWTG) Unveils Lighter Shaft amid Women's Golf Boom
- InvestorNewsBreaks - Newton Golf Company Inc. (NASDAQ: NWTG) Names Jeff Clayborne as CFO to Drive Next Phase of Growth
Platinum Group Metals Ltd. (TSX: PTM) (NYSE American: PLG)
The QualityStocks Daily Newsletter would like to spotlight Platinum Group Metals Ltd. (TSX: PTM) (NYSE American: PLG).
The platinum market recorded a deficit of approximately 992,000 ounces in 2024 and is forecast to remain in substantial undersupply through 2025.
This tightening supply-demand balance has prompted a sharp rally in platinum prices.
Platinum Group Metals Ltd. is working to address a portion of the world's platinum need.
The platinum market is entering its third straight year of major structural supply deficits—a situation that is adding both pressure and opportunity for players such as Platinum Group Metals (NYSE American: PLG) (TSX: PTM) , a development-stage mining company focused on its flagship Waterberg project in South Africa to help unlock new platinum supply while exploring innovative industrial applications for platinum and palladium.
Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) is the operator of the Waterberg Project, a bulk underground platinum group metals (PGM) deposit discovered by Platinum Group in 2011 and located on the Northern Limb of the Bushveld Complex in South Africa. The Waterberg Project is planned as a fully mechanised platinum, palladium, rhodium and gold mine, including by-product copper and nickel production, and is projected to be one of the largest and lowest cost PGM mines globally.
The project is a joint venture between Platinum Group; integrated PGM producer Impala Platinum Holdings Ltd. (OTCQX: IMPUY); Japanese consortium HJ Platinum, which includes trading house Hanwa Co. and the government-backed Japan Organization for Metals and Energy Security (JOGMEC); and local empowerment partner Mnombo Wethu Consultants (Pty) Ltd. Platinum Group has an effective 50.22% interest in the Waterberg Project.
The company’s primary business objective is to advance the Waterberg Project to a development and construction decision. An update to the 2019 Definite Feasibility Study is expected in 2024.
PGMs are essential and precious metals that include platinum, palladium, rhodium, iridium, osmium and ruthenium. These metals are known for their purity, high melting points and unique catalytic properties. They are utilized in a number of industrial processes, technologies and commercial applications and play a critical role in autocatalysis and pollution control in the automotive sector. The bulk of global PGMs are mined in Southern Africa and Russia.
The unique properties of PGMs are being applied to various technologies as possible solutions for more efficient energy generation and storage, which may create new demand for PGMs. The company’s battery technology initiative through Lion Battery Technologies Inc., using platinum and palladium in lithium battery technologies, represents one such new opportunity in the high-profile lithium battery research and innovation field.
Platinum Group Metals Ltd. founded Lion Battery Technologies Inc. in partnership with Anglo American Platinum Ltd. (AMS: JNB) to support the use of palladium and platinum in lithium battery applications. Lion Battery has entered into an agreement with Florida International University to further advance a research program that uses platinum and palladium to unlock the potential of Lithium Sulfur (Li-S) battery chemistries.
Platinum Group is headquartered in Vancouver, B.C., and Johannesburg, South Africa.
Waterberg Project
Platinum Group’s sole material mineral property, the Waterberg Project, is presently in process with pre-construction permitting; engineering work, including road upgrade and traffic studies; finalization of power and water infrastructure design; and construction camp design.
The company’s principal product from the Waterberg Project is planned to be a PGM-bearing concentrate. The concentrate will contain economic amounts of six elements comprising platinum, palladium, rhodium, gold, copper and nickel. The company’s partner in the Waterberg Project, Impala Platinum Holdings, has acquired a right of first refusal to enter into an offtake agreement, on commercial arm’s-length terms, for the smelting and refining of mineral products from the Waterberg Project.
The Waterberg project has proven and estimated reserves of 19.5 million ounces of PGMs and gold. When fully operational, the mine is projected to produce more than 400,000 ounces of PGMs annually during the peak period of steady state production. The life of the mine is projected at 45 years.
South Africa’s PGM mining sector remains closely tied to economic developments in the global automotive industry, which in 2022 accounted for approximately 43% of the total global demand for platinum and 82% of the total global demand for palladium.
Market Opportunity
According to a report from Straits Research, a global market and business research firm, the worldwide platinum market had an estimated value of $7.72 billion in 2022 and is projected to reach $11.95 billion by 2031. That represents a CAGR of 5.13% over the forecast period.
Platinum, one of the rarest of precious metals, is about 30 times scarcer than gold. It is crucial to the automotive and electronics industries and is also used to make jewelry. Stricter emissions regulations around the world have led to an increased demand for platinum to be used in catalytic converters to reduce automotive emission, the report states.
A report from Allied Market Research estimated the global palladium market at $16.3 billion in 2021 and projects the market will reach $28.6 billion by 2031, growing at a CAGR of 5.8% over the period.
Palladium is also used in automotive catalytic converters for reducing emissions and in jewelry, dentistry, watchmaking, blood sugar test strips, aircraft spark plugs, surgical instruments, electrical contacts and musical instruments.
An increase in demand for consumer electronics has driven demand for palladium-based multilayer ceramic capacitors (MLCC) used to store energy in electronic devices such as broadcasting equipment, mobile telephones, computers, electronic lighting and high voltage circuits, according to the report.
Management Team
Frank R. Hallam is Co-Founder, Director, President and CEO of Platinum Group. He has over 30 years of experience in the mining, minerals and petroleum industry as an operator, principal and founder. He was a co-founder and former CFO of MAG Silver Corp. He was also co-founder and director of West Timmins Mining Inc. and a director of Lake Shore Gold Corp. In addition, he was CFO and director with gold exploration company Tan Range Exploration Corp. He is a Chartered Professional Accountant and was formerly an auditor in the public mining practice of PwC. He holds a Bachelor of Business Administration from Simon Fraser University.
Greg Blair is CFO of Platinum Group. He has been with Platinum Group since 2010 in various roles, most recently as Interim CFO. Prior to joining Platinum Group, he was at a public accounting firm working on public company (mainly mining) audits. He is a Chartered Professional Accountant and holds a degree in Economics from Simon Fraser University and has completed the Canadian Securities Course.
Kris Begic is VP Corporate Development of Platinum Group. He has over 25 years of experience in the mining industry and capital markets and has been involved with the raising of over $500 million for various exploration and development projects globally. His efforts are focused on project generation, mergers and acquisitions, capital markets, investor relations and marketing.
Additional Resources
Platinum Group Metals Ltd. (NYSE American: PLG), closed Wednesday's trading session at $1.55, up 1.3072%, on 16,783 volume. The average volume for the last 3 months is 1,473,691 and the stock's 52-week low/high is $0.99/$2.27.
Recent News
- Platinum Group Metals Ltd. (TSX: PTM) (NYSE American: PLG) - Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Advances Waterberg Project Amid Third Straight Year of Platinum Deficits
- Gold Holds Steady as Dedollarization Picks Pace
- Protests Push Indonesian Government to Cancel Nickel Mining Licenses in Raja Ampat
Solowin Holdings (NASDAQ: SWIN)
The QualityStocks Daily Newsletter would like to spotlight Solowin Holdings (NASDAQ: SWIN).
Solowin Holdings offers diversified exposure to both traditional financial services and next-generation digital assets.
The company leverages regulatory licenses in Hong Kong to serve global high-net-worth and institutional investors.
Solowin delivers brokerage, investment banking, asset management, and Web3 services across its Solomon Win and Solomon VA+ platforms, offering clients seamless access to both traditional and digital financial solutions.
Strategic investments, such as its $10M contribution to AlloyX, an Asia-based stablecoin infrastructure firm, highlight Solowin's proactive role in fintech innovation.
Led by seasoned executives with decades of capital markets experience, the company is positioned for sustained global expansion.
Solowin Holdings (NASDAQ: SWIN) is a versatile financial services provider focused on delivering comprehensive investment solutions from traditional finance as well as decentralized finance to high-net-worth and institutional clients. Operating through its wholly owned subsidiary, Solomon JFZ (Asia) Holdings Limited, Solowin is licensed by the Hong Kong Securities and Futures Commission and offers access to a full suite of financial services through its secure, one-stop electronic platform, Solomon Win.
Driven by a vision to create a modernized financial services infrastructure, especially to bridging traditional finance and the Web3 technology, Solowin has prioritized innovation, agility, and client-first experiences. The firm has experienced robust growth, aligning itself with evolving capital markets and emerging technologies. Its investment strategy is designed to enable seamless access to capital markets and diversified investment opportunities through cutting-edge financial technology.
Solowin is committed to building a global brand rooted in client success, regulatory compliance, and operational excellence. Its mission is to empower clients with flexible, integrated tools to grow and protect wealth in an increasingly complex financial landscape.
Portfolio
Solowin’s operations span five core verticals: securities brokerage, investment banking, asset management, virtual assets, and wealth management. Through its Solomon Win platform, the company provides individual and institutional clients with seamless access to financial markets around the world.
In investment banking, Solowin offers strategic advisory and capital formation services including IPO/SPAC listings, follow-on offerings, private placements, and debt financing. Its team assists issuers in aligning their business objectives with optimized listing strategies and investor targeting. Solowin also supports clients through financial advisory services such as mergers and acquisitions, business restructuring, and capital strategy development, alongside risk management and tax compliance services.
In wealth and asset management, Solowin delivers personalized financial planning via its securities brokerage and integrated investment solutions. Clients can access both in-house funds and top-tier international funds through the Solomon VA+ App, which also supports managed account services. On the frontier of fintech, Solowin offers Web3-based solutions such as virtual asset ETFs, cryptocurrencies, security token offerings, and tokenized real-world assets—positioning itself as a key player in the evolving digital finance space.
Market Opportunity
Solowin operates at the intersection of traditional finance and Web3 innovation, targeting a rapidly expanding global wealth management and fintech market. According to a report by Boston Consulting Group, global assets under management are projected to reach $147.4 trillion by 2027, up from $111.2 trillion in 2021, driven by increased demand for personalized and tech-enabled financial services. Additionally, the virtual asset market is poised for significant growth, with Boston Consulting Group forecasting that the tokenization of global illiquid assets could reach $16 trillion by 2030.
Hong Kong’s progressive stance on virtual assets has also positioned it as a regional hub for digital finance. Regulatory support from the Securities and Futures Commission has opened the door for regulated crypto trading platforms and tokenized asset solutions, which aligns with Solowin’s digital-first approach.
As wealth migrates toward hybrid portfolios combining traditional and virtual assets, Solowin is uniquely positioned to capitalize on both sectors.
Leadership Team
Peter Lok, Chief Executive Officer, an accomplished finance professional with extensive expertise in fund management, capital markets, and fundraising. His strategic insights in finance and capital allocation have been instrumental in driving capital growth.
Lily Liu, Chief Financial Officer, has more than a decade of experience in corporate finance, investment banking, and financial services. Her background includes IPOs, mergers and acquisitions, and private placements in both Hong Kong and U.S. capital markets, with a strong focus on risk management.
Ben Cheng, Chief Operating Officer, has 15+ years of operational expertise in securities brokerage and asset management. His specialties include regulatory compliance and Anti-Money Laundering/Counter-Financing of Terrorism (AML/CFT) oversight.
Investment Considerations
- Solowin Holdings offers diversified exposure to both traditional financial services and next-generation digital assets.
- The company leverages regulatory licenses in Hong Kong to serve global high-net-worth and institutional investors.
- Solowin delivers brokerage, investment banking, asset management, and Web3 services across its Solomon Win and Solomon VA+ platforms, offering clients seamless access to both traditional and digital financial solutions.
- Strategic investments, such as its $10M contribution to AlloyX, an Asia-based stablecoin infrastructure firm, highlight Solowin’s proactive role in fintech innovation.
- Led by seasoned executives with decades of capital markets experience, the company is positioned for sustained global expansion.
Additional Resources
Solowin Holdings (NASDAQ: SWIN), closed Wednesday's trading session at $2.03, even for the day, on 3,934 volume. The average volume for the last 3 months is 264,297 and the stock's 52-week low/high is $1.16/$4.5249.
Recent News
- Solowin Holdings (NASDAQ: SWIN) - Solowin Holdings (NASDAQ: SWIN) Is 'One to Watch'
- Solowin and Partners Invest US$10M in AlloyX's Pre-A Funding Round
- Solowin Holdings (Nasdaq: SWIN) was pleased to co-host an exclusive event with FRED Jewelry and Legend Magazine in Hong Kong
Intelligent Bio Solutions Inc. (NASDAQ: INBS)
The QualityStocks Daily Newsletter would like to spotlight Intelligent Bio Solutions Inc. (NASDAQ: INBS).
Intelligent Bio Solutions (NASDAQ: INBS) announced that Managed Waste Service (MWS), a leading Australian waste management provider, will implement INBS' Intelligent Fingerprinting Drug Screening System across its New South Wales operations. Covering over 20 remote land clearing and green waste sites, this marks MWS's first shift to in-house, on-site drug testing for pre-employment, random, and for-cause purposes. The fingerprint-based system delivers non-invasive results in under ten minutes, enabling rapid safety decisions without disrupting field operations. INBS continues to expand its reach into safety-critical industries, with its scalable, sweat-based drug testing now in use by over 450 organizations across 24 countries.
To view the full article, visit https://ibn.fm/BDqK5
Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company pioneering rapid, non-invasive diagnostics through its proprietary Intelligent Fingerprinting Drug Screening System. By utilizing fingerprint sweat analysis, the company offers a cost-effective, hygienic solution to detect recent drug use — targeting substances commonly found in workplace settings such as opiates, cocaine, methamphetamine, and cannabis. This innovative approach positions INBS to transform drug testing protocols, particularly in industries where safety and speed are mission critical.
The company’s vision is to redefine drug screening by removing the pain points of traditional testing methods, including biohazardous waste, privacy concerns, and long result turnaround times. With results in under 10 minutes and no need for gender-specific collectors or laboratory facilities, the system empowers companies and organizations to screen more efficiently. INBS continues to drive adoption in international markets, with customers spanning construction, logistics, healthcare, government, and drug treatment sectors.
INBS’s mission is centered on delivering accessible, transformative solutions that improve lives and operational safety. As the company expands toward a planned U.S. market launch in 2025, it is also strengthening its intellectual property portfolio and localizing solutions for Spanish-speaking regions.
The company is headquartered in New York, New York.
Intelligent Fingerprinting Drug Screening System
Intelligent Bio Solutions’ flagship offering is the Intelligent Fingerprinting Drug Screening System, a portable, three-part solution that includes a fingerprint collection cartridge, a lateral flow-based DSR-Plus reader, and software for rapid drug screening. Designed to be used on-site, this system eliminates the complexities and hazards of urine and saliva tests, offering a clean, fast, and non-invasive alternative.
The system screens for a broad range of substances including opiates, methamphetamine, cocaine, cannabis, benzodiazepines, and more. Its cost advantage is significant — point-of-care fingerprint tests cost approximately $20, compared to $300 for typical urine or saliva testing. The platform includes over 1,000 DSR-Plus Readers installed across customer sites, supporting a base of more than 450 active customer accounts globally. In clinical studies, the system demonstrated 94.1% accuracy and 100% specificity, providing a credible foundation for future FDA approvals and market expansion.
In addition to drug screening, INBS is developing a proprietary biosensor platform designed to detect specific biomarkers from non-invasive samples such as sweat, saliva, and interstitial fluid. These additional applications remain under development.
Market Opportunity
Intelligent Bio Solutions operates at the intersection of workplace safety, public health, and diagnostic innovation. The company is targeting the drug screening products market, which is projected to reach $14.9 billion by 2030, growing at a compound annual growth rate (CAGR) of 12.1%, according to Research and Markets.
In the U.S., substance abuse is a $400 billion issue, with more than 70% of individuals using illicit drugs or alcohol currently employed. This presents an urgent need for scalable, workplace-compatible screening technologies. Industries such as transportation, construction, mining, and healthcare are among the highest adopters of employee drug testing protocols, driven by regulatory requirements and safety imperatives.
INBS’s non-invasive solution is well-positioned to capitalize on trends toward less invasive, faster, and more convenient testing methods — potentially displacing legacy systems reliant on urine or saliva testing, which have longer turnaround times and greater administrative burdens.
Leadership Team
Harry Simeonidis, Chief Executive Officer, has over 25 years of experience across the healthcare, pharmaceutical, and life sciences industries. He previously served as General Manager for Surgery, Asia Pacific at GE Healthcare. Prior to that, he was President and CEO of GE Healthcare ANZ, where he led significant market share growth.
Spiro Sakiris, Chief Financial Officer, brings 34 years of expertise in accounting, taxation, IPO preparation, and capital raising. He is highly experienced with IFRS and U.S. GAAP applications in the life sciences sector and is a member of the Institute of Chartered Accountants of Australia & New Zealand.
Investment Considerations
- INBS offers a patented, non-invasive testing solution positioned to disrupt a global drug screening market projected to reach $14.9 billion by 2030.
- The company is revenue-generating, with 148% year-over-year growth in FY 2024 and 450+ active customer accounts.
- Its Intelligent Fingerprinting system provides rapid, on-site results with a lower cost and higher convenience compared to traditional methods.
- The Intelligent Fingerprinting Drug Screening System is already in commercial use internationally, and a U.S. product launch is planned for 2025, with FDA 510(k) clearance in process and new patent protections underway.
- INBS is led by a seasoned executive team with global healthcare and commercialization experience.
Additional Resources
Intelligent Bio Solutions Inc. (NASDAQ: INBS), closed Wednesday's trading session at $1.85, off by 4.1451%, on 1,316 volume. The average volume for the last 3 months is 142,144 and the stock's 52-week low/high is $1/$3.
Recent News
- Intelligent Bio Solutions Inc. (NASDAQ: INBS) - BioMedNewsBreaks - Intelligent Bio Solutions Inc. (NASDAQ: INBS) to Deploy Fingerprint Drug Testing System Across MWS Sites in Australia
- BioMedNewsBreaks - Intelligent Bio Solutions Inc. (NASDAQ: INBS) CEO Highlights Fingerprint Drug Testing on BioMedWire Podcast
- BioMedNewsBreaks - Intelligent Bio Solutions Inc. (NASDAQ: INBS) Expands U.S. Forensic Market Presence Through SMARTOX Partnership
Soligenix Inc. (NASDAQ: SNGX)
The QualityStocks Daily Newsletter would like to spotlight Soligenix Inc. (NASDAQ: SNGX).
Psoriasis affects approximately 3% of the adult population in the United States, translating to more than 7.5 million individuals.
By using visible light, Soligenix's SGX302 aims to mitigate risks while effectively reducing inflammation and promoting skin healing.
A phase 2a study demonstrated that SGX302 was well tolerated, with no significant adverse events reported.
Psoriasis is more than just a skin condition — it's a lifelong autoimmune disorder that disrupts daily life with painful, inflamed patches and an emotional toll that can be just as severe as the physical symptoms. Soligenix (NASDAQ: SNGX) is at the forefront of developing innovative therapies for this condition, notably SGX302 (synthetic hypericin), a novel treatment currently undergoing Phase 2a clinical trials aimed at addressing mild to moderate psoriasis.
Soligenix Inc. (NASDAQ: SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases with high unmet medical needs. Operating through two key segments, the company’s Specialized BioTherapeutics division is dedicated to oncology and inflammation therapies, while its Public Health Solutions segment advances vaccines and therapeutics targeting biothreats and infectious diseases.
The company is actively advancing multiple late-stage clinical programs, including HyBryte™ (SGX301), a novel photodynamic therapy for cutaneous T-cell lymphoma (CTCL). Additional candidates in development target psoriasis (SGX302), oral mucositis (SGX942), and Behçet’s disease (SGX945), while its public health efforts focus on heat-stable vaccines for ricin poisoning (RiVax®), Ebola (SuVax™), and Marburg (MarVax™) viruses, that have been supported by non-dilutive government grants and contracts of approximately $60 million to date.
With a diversified pipeline, multiple orphan and fast-track designations, and collaborations with government agencies, Soligenix is uniquely positioned for potential regulatory approvals and commercialization.
The company is headquartered in Princeton, New Jersey.
Pipeline and Development Programs
Specialized BioTherapeutics
Soligenix’s Specialized BioTherapeutics division develops treatments for oncology and inflammatory diseases, focusing on conditions with few or no effective therapeutic options. HyBryte™ (synthetic hypericin) has completed a Phase 3 study for CTCL, demonstrating statistically significant efficacy, and a second confirmatory Phase 3 trial is actively enrolling patients to support potential regulatory submissions worldwide. If approved, it would be the first non-mutagenic photodynamic therapy for early-stage CTCL, addressing an unmet medical need. It has received orphan drug designations in the U.S. and Europe, as well as Fast Track designation in the U.S.
SGX302, a photodynamic therapy based on the same active ingredient as HyBryte™, is in clinical development for mild-to-moderate psoriasis, with positive Phase 1/2 proof-of-concept results, it is actively enrolling patients in a Phase 2a clinical trial.
SGX942, designed to reduce inflammation and tissue damage in oral mucositis associated with cancer treatment, is progressing as a potential first-in-class therapy.
SGX945, targeting aphthous ulcers in Behçet’s disease, is actively enrolling in a Phase 2a clinical trial and has received fast-track designation, highlighting the urgency of developing effective treatments for this rare inflammatory condition.
Public Health Solutions
The company’s Public Health Solutions segment focuses on medical countermeasures for biothreats and emerging infectious diseases, leveraging non-dilutive government funding to advance its programs. RiVax®, a ricin toxin vaccine, has demonstrated strong preclinical and early clinical results and may be eligible for government procurement under the Strategic National Stockpile initiative.
The company’s RiVax®, as well as its vaccine candidates for Ebola and Marburg viruses are based on its proprietary ThermoVax® technology, which stabilizes vaccines for long-term storage without refrigeration. This approach could be transformative in regions where maintaining cold-chain logistics is challenging.
The ongoing development of these vaccines is supported by funding from NIH, BARDA, and DTRA, with the potential for up to three priority review vouchers (PRVs) upon regulatory approval, to be used for future programs or sold. Notably, PRVs have previously sold for roughly $100 million.
Market Opportunity
Soligenix targets markets with significant commercial potential, focusing on rare diseases and biodefense applications. HyBryte™ addresses CTCL, a disease affecting over 68,000 patients across the U.S. and Europe, with a total market opportunity exceeding $250 million. SGX302, the company’s therapy for mild-to-moderate psoriasis, serves a much larger population, as over eight million people in the U.S. are affected by the condition, representing a global market opportunity exceeding $1 billion.
SGX942, developed for oral mucositis in head and neck cancer patients, is aimed at a market worth more than $500 million, while SGX945 for Behçet’s disease serves a niche segment valued at over $200 million worldwide.
In addition to its rare disease programs, Soligenix’s Public Health Solutions division has the potential to generate significant revenue through government procurement contracts. By focusing on both orphan drug markets and government-funded biodefense initiatives, Soligenix has positioned itself for sustained revenue growth through multiple high-value opportunities.
Leadership Team
Christopher J. Schaber, PhD, Chairman, President & CEO, brings to the company more than 35 years of experience in the biopharmaceutical industry. Before joining Soligenix, he held senior and operational leadership roles at Discovery Laboratories, Acute Therapeutics, Ohmeda Pharmaceuticals, The Liposome Company, and Wyeth Ayerst Laboratories. He has extensive expertise in drug development, regulatory affairs, and corporate strategy, positioning him to drive Soligenix’s growth and advancement toward commercialization.
Richard Straube, MD, Chief Medical Officer, has more than 35 years of experience in drug development and clinical research. Prior to joining Soligenix, he held key leadership roles at Stealth Peptides, INO Therapeutics, Ohmeda Pharmaceuticals, and Centocor. Throughout his career, he has played a crucial role in bringing innovative therapies to market, particularly in inflammatory diseases and immunology, making him a valuable asset in advancing Soligenix’s late-stage clinical programs.
Oreola Donini, PhD, Chief Scientific Officer, has more than 20 years of experience in pharmaceutical research and development, with expertise in immunology, inflammation, and rare diseases. Before joining Soligenix, she held leadership positions at Inimex Pharmaceuticals, ESSA Pharma, and Kinetek Pharmaceuticals, where she worked on novel drug discovery and translational medicine. Her experience in preclinical research and product development supports Soligenix’s continued innovation in biopharmaceuticals.
Jonathan Guarino, CPA, CGMA, Chief Financial Officer, has over 25 years of experience in corporate finance and strategic financial planning. Before joining Soligenix, he held financial leadership positions at Hepion Pharmaceuticals, Covance, BlackRock, and Barnes & Noble. His expertise in financial management, accounting, and capital markets plays a critical role in Soligenix’s financial strategy and operational efficiency.
Investment Considerations
- Soligenix has multiple late-stage assets with orphan and fast-track designations, providing a clear regulatory pathway toward potential approvals.
- The company’s pipeline has a total addressable market exceeding $2 billion, spanning rare diseases, inflammation, and biothreat applications.
- Soligenix has benefited from significant non-dilutive government funding, which reduces operational expenses and financial risk while supporting its public health initiatives.
- The company is well-positioned for multiple development and regulatory catalysts, and commercial milestones, with lead candidates in cutaneous T-cell lymphoma, psoriasis, oral mucositis, and Behçet’s disease.
- Soligenix is led by an experienced management team with a strong track record of success.
Additional Resources
Soligenix Inc. (NASDAQ: SNGX), closed Wednesday's trading session at $1.785, off by 0.8333333%, on 258 volume. The average volume for the last 3 months is 20,872 and the stock's 52-week low/high is $1.68/$14.8299.
Recent News
- Soligenix Inc. (NASDAQ: SNGX) - Soligenix Inc. (NASDAQ: SNGX) Proprietary Therapy Shows Promise in Treatment of Psoriasis
- Study Finds the Overall Prevalence of Psoriasis in the US Unchanged
- Soligenix Inc. (NASDAQ: SNGX) Makes Advancement in Proprietary Treatment for Behçet's Disease
Mullen Automotive Inc. (NASDAQ: MULN)
The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).
President Donald Trump has signed a measure that will override California's electric vehicle mandate and prevent the state from compelling automakers to cut their greenhouse gas emissions at an accelerated rate. The move comes several weeks after the GOP Senate voted in favor of blocking California's 2035 electric vehicle mandate and will deal a significant blow to the state's electrification plans. Tesla, which is currently dealing with falling sales due to brand issues, will also be affected by President Trump's recent announcement. The controversial GOP president recently signed several congressional measures designed to rescind California emission standards that were designed to phase out internal combustion engine (ICE) vehicle sales and accelerate the state's transition to battery electric vehicles (BEVs). As California is the largest automobile market in the U.S., and several other states have also adopted California's emission standards, they would have forced most automakers to spend millions upon millions of dollars on electrifying their vehicle lineups. After his recent fallout with Tesla CEO Elon Musk, President Trump seems to be escalating his anti-electric vehicle agenda. The loss of federal tax incentives coupled with the loss of California's electric vehicle mandate will undoubtedly be hard on Tesla, especially now that the Texas-based automaker is facing lots of brand blowback and diminishing sales. Other American startups like Mullen Automotive Inc. (NASDAQ: MULN) will now have to rethink their market penetration strategies in light of the growing bottlenecks triggered by Trump's stance on EVs and renewable energy.
Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.
Commencement of Trading on Nasdaq
On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.
“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”
The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.
The Mullen FIVE
The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.
The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.
Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.
LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.
Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.
Expansion of Manufacturing Capacity
On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.
Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.
On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.
EV Market Outlook
The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.
Management Team
David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.
Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.
Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.
Mullen Automotive Inc. (MULN), closed Wednesday's trading session at $1.32, off by 20%, on 2,769,544 volume. The average volume for the last 3 months is 4,189,702 and the stock's 52-week low/high is $1.32/$169182000.
Recent News
- Mullen Automotive Inc. (NASDAQ: MULN) - Trump Signs Measure Overriding EV Mandate, a Blow to Musk and California
- Why Renewable Energy Glitches Aren't Necessarily Signals of Failure
- Google Teams Up with CIP on Wind Energy Project in Taiwan
ONAR Holding Corp. (OTCQB: ONAR)
The QualityStocks Daily Newsletter would like to spotlight ONAR Holding Corp. (OTCQB: ONAR).
ONAR Holding Corp. (OTCQB: ONAR) is a leading marketing technology company and marketing agency network focused on delivering integrated, AI-driven solutions to accelerate revenue growth for its clients. Through an agile agency network specializing in performance marketing, full-service healthcare marketing, experiential marketing, and technology incubation, ONAR provides best-in-class services to a growing roster of clients worldwide.
Built on a foundation of innovation and operational excellence, ONAR’s vision is to redefine marketing services by leading with technological advancement. With employees across five continents, the company is aggressively expanding its team to support both organic growth and an active acquisition pipeline. ONAR’s strategic growth model focuses on growing and acquiring proven agencies under one umbrella to deliver superior service offerings across industries.
ONAR’s mission is to drive measurable client success through integrated, high-impact marketing solutions that blend creativity, data science, and technology. As it continues to expand, ONAR is focused on building a global marketing services network that serves companies ranging from $10 million to $300 million in revenue.
The company is headquartered in Miami, Florida.
Portfolio
ONAR’s operations are organized across a network of specialized agencies that together serve more than 45 clients across a wide range of industries. Each agency brings deep domain expertise and a results-driven approach:
- Storia: A premier performance marketing agency specializing in brand growth, paid media, and SEO. With a focus on data-driven excellence, Storia delivers highly targeted marketing strategies that maximize ROI across digital platforms. The agency partners with leading brands to drive measurable revenue outcomes and long-term brand equity.
- Of Kos: A full-service healthcare marketing agency committed to redefining the patient experience. Of Kos partners with healthcare professionals to deliver integrated campaigns that not only increase patient engagement but also elevate the standard of care across the healthcare landscape. Its work bridges marketing innovation and healthcare expertise to create real impact.
- CHALK: An experiential marketing agency that transforms bold ideas into unforgettable, immersive experiences. CHALK’s team of event architects specializes in designing events that break boundaries — from brand activations and pop-ups to major corporate experiences — creating lasting emotional connections between brands and audiences.
- ONAR Labs: The company’s pioneering technology incubator, ONAR Labs, brings together data scientists, engineers, and industry experts to develop proprietary marketing technologies. Every product is rigorously battle-tested within the agency network before commercialization, ensuring that ONAR Labs delivers real-world solutions that enhance marketing performance and client success.
Market Opportunity
ONAR operates at the intersection of marketing services and marketing technology, two sectors undergoing rapid evolution and expansion. The global digital marketing software market alone is projected to reach $264.15 billion by 2030, expanding at a CAGR of 19.4%, according to Grand View Research. Meanwhile, healthcare marketing and experiential marketing are experiencing renewed momentum, as companies seek to create more personalized and immersive customer experiences.
With its integrated, AI-driven platform and expertise across multiple high-growth verticals, ONAR is well positioned to capture a growing share of the marketing spend from mid-sized to large enterprise clients. As businesses increasingly prioritize digital transformation, customer experience, and data-driven marketing, ONAR’s diversified offerings and proprietary technologies through ONAR Labs create meaningful competitive advantages in a highly fragmented market.
Leadership Team
Claude Zdanow, Chief Executive Officer, is a seasoned entrepreneur and business leader with deep experience scaling service organizations and technology platforms. Prior to founding ONAR, he built and successfully exited multiple companies in marketing and media, combining creative vision with operational discipline to drive measurable client growth.
Chris Becker, President, brings extensive operational and strategic expertise to ONAR, focusing on driving agency performance and expanding the company’s integrated service offering. His leadership emphasizes operational rigor, client success, and scaling the company’s footprint across industries and regions.
Patricia Kaelin, Chief Financial Officer, oversees ONAR’s financial operations and strategic planning. A distinguished financial executive with more than 25 years of experience in scaling high-growth companies and leading finance teams at both public and private companies, she expertly manages financial strategy, M&A transactions, and provides a strong foundation for ONAR’s continued expansion and acquisition initiatives.
Sam Mendez, Chief of Staff, fosters seamless collaboration across the organization. She expertly manages strategic projects, facilitates clear communication channels, and acts as a key point of contact to maximize the executive team’s impact and advance organizational goals.
Investment Considerations
- ONAR is scaling a diversified, AI-driven marketing network addressing multiple high-growth industry verticals.
- The company is actively pursuing an acquisition-driven expansion strategy to grow its marketing agency network.
- ONAR Labs provides a proprietary technology pipeline, offering additional revenue streams beyond traditional marketing services.
- A strong leadership team with proven track records in business growth, financial management, and technology commercialization positions the company for long-term success.
- ONAR’s focus on middle market and growth-stage clients aligns with sectors expected to see a sustained rise in marketing spend over the next decade.
Additional Resources
ONAR Holding Corp. (OTCQB: ONAR), closed Wednesday's trading session at $0.0649, even for the day, on 1 volume. The average volume for the last 3 months is 1,970 and the stock's 52-week low/high is $0.03/$0.167.
Recent News
- ONAR Holding Corp. (OTCQB: ONAR) - ONAR Holding Corp. (ONAR) Takes the Lead in AI-Driven Marketing as CEO Shares Vision
- From Basement Studio Success to Marketing Visionary: CEO of ONAR Holding Corp. (ONAR)
- InvestorNewsBreaks - ONAR Holding Corp. (OTCQB: ONAR) Appoints Howard Palefsky to Board, Expands Governance Leadership
Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF)
The QualityStocks Daily Newsletter would like to spotlight Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF).
Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF) is a junior resource company focused on monetizing high-grade mineral assets in British Columbia. With a unique dual-pronged model, the company combines solid operational revenues from its wholly-owned, state-of-the-art gold and silver mill with the long-term upside of 100%-owned copper, silver, and gold exploration projects. This approach allows Nicola to fund ongoing development while minimizing equity dilution.
The company’s strategy centers on aligning infrastructure and permitting advantages with mineral-rich geology, positioning it to process its own, as well as third-party high-grade gold and silver mines via partnerships, to advance its own exploration targets. Key agreements with gold producers and concentrating sales contracts provide stable cash flow, making Nicola rare among juniors in its ability to internally support growth. Its solid balance sheet and business acumen have allowed it to take stakes in other near-term gold producers, including a 75% economic stake in Dominion Gold, which commences a bulk sample in 2H 2025.
Nicola is leveraging its platform of permitted infrastructure, strategic project locations, and deep technical expertise to build shareholder value in a low-risk, high-reward framework. The company is headquartered in Vancouver, British Columbia.
Projects
Nicola Mining’s project portfolio includes high-grade copper, silver, and gold assets located in mineral-rich regions of British Columbia. Each project is 100%-owned or majority-controlled, with strong exploration potential and the necessary permits to advance development.
New Craigmont Copper Project
Nicola’s flagship asset, the New Craigmont Project, is a historic producer of over 900 million pounds of copper. Since acquiring 100% ownership in 2015, the company has drilled over 18,000 meters and identified significant skarn-hosted and porphyry-style mineralization. Recent drilling in 2024 confirmed 52.9 meters at 1.03% Cu (Hole NC-24-002), supporting the presence of a large-scale copper system. The project benefits from paved road access, connection to BC Hydro’s grid, and proximity to urban centers.
Treasure Mountain Silver Project
This 100%-owned past-producing mine has a Major Mines permit (M-239) and an NI 43-101 compliant resource estimate. The site includes multiple silver-lead-zinc veins and is permitted to extract up to 60,000 tonnes annually. Nicola is evaluating potential reactivation or joint venture options. Resource estimates include indicated resources of 52,000 tonnes grading 18.1 oz/t Ag, 3.26% Pb, and 3.4% Zn, and inferred resources of 161,000 tonnes grading 22.0 oz/t Ag, 2.48% Pb, and 3.86% Zn.
Dominion Creek Project (Au-Ag)
Nicola holds a 50% land ownership and 75% economic stake in this gold-silver project. Located 43 km from Wells, British Columbia, the site has returned grab samples averaging 61.3 g/t Au and 173.7 g/t Ag. The company has received its final permit and plans to extract a 10,000-tonne bulk sample in 2025, which will be processed at its Merritt Mill facility.
Operations
In addition to its exploration assets, Nicola Mining operates a suite of permitted industrial facilities in British Columbia that generate revenue and support the company’s broader development strategy. These assets form the backbone of Nicola’s self-sustaining business model.
Merritt Mill & Tailings Facility
Nicola owns and operates British Columbia’s only provincially permitted toll mill for gold and silver, a $30 million flotation facility located near Merritt. Gold production began in 2023. The facility is supported by long-term Milling and Profit Share Agreements with companies including Osisko Development Corporation, Blue Lagoon Resources, and Talisker Resources.
Sand & Gravel Pit / Rock Quarry / Ready-Mix Concrete Plant
Nicola also operates a permitted gravel pit (100,000 t/year), rock quarry (1,500 t/day), and is set to launch a ready-mix cement plant in Q2 2025. These operations, run in partnership with local First Nations, generate stable cash flow to support exploration efforts.
Market Opportunity
Nicola Mining is uniquely positioned in southern British Columbia, a jurisdiction recognized for its mining-friendly policies, skilled labor force, and robust infrastructure. The New Craigmont Project is geologically situated within the Guichon Creek Batholith, a region hosting some of Canada’s largest copper mines, including Highland Valley. Exploration data from 2023 and 2024 support the potential presence of both skarn and porphyry systems, increasing the strategic value of Nicola’s holdings.
The company’s other assets, including Treasure Mountain and Dominion Creek, are located in historically productive areas with high-grade mineralization and established access routes. Dominion Creek, in particular, sits atop the Isaac Lake Fault system—identified in British Columbia’s RGS (Regional Geochemical Survey) as a highly anomalous gold-silver corridor. Nicola’s integrated production model enables it to generate revenue while advancing these exploration programs without excessive dilution, providing a distinct advantage in a volatile commodities market.
Leadership Team
Peter Espig, Chief Executive Officer & Director, is a former diamond driller who spearheaded Nicola through a restructuring into its recent growth. He brings over $2 billion in private equity transaction experience, is a pioneer of SPACs, and has held senior positions at Goldman Sachs Japan and Olympus Capital.
Will Whitty, VP of Exploration, brings to the company over 15 years of experience in copper and gold exploration. He previously worked at Freeport-McMoRan and Nevada Gold Mines. He holds a master’s degree from the Mineral Deposit Research Unit (MDRU) at the University of British Columbia.
Bill Cawker, Corporate Development, manages investor relations, communications, and corporate governance. He joined Nicola in 2023 and brings extensive small-cap public markets experience, along with a degree in economics from the University of British Columbia.
Sam Wong, Chief Financial Officer, is a CPA with over 18 years of experience in the mining sector. He previously held executive roles at several publicly listed resource companies. He began his career at Deloitte LLP in Vancouver.
Investment Considerations
- High-Grade Copper Opportunity: 100% ownership of the New Craigmont Project, one of British Columbia’s most promising high-grade copper exploration targets, strategically located adjacent to Canada’s largest copper mine (Highland Valley Copper).
- Immediate Revenue Generation: Operates British Columbia’s only permitted mill capable of processing third-party gold and silver ore, with current throughput supporting strong, near-term cash flow.
- Diverse Revenue Streams: Revenue growth fueled by commercial milling operations, gold concentrate sales, and active aggregate production — providing self-funded exploration and reducing reliance on capital raises.
- Strategic Location & Infrastructure: Centrally located near major transportation routes and mining services, providing cost advantages and operational efficiencies.
- Proven Leadership Team: Led by a management group with extensive track records in mining operations, project development, and capital markets, driving disciplined growth and long-term value creation.
Additional Resources
Nicola Mining Inc. (OTCQB: HUSIF), closed Wednesday's trading session at $0.357, up 10.0493%, on 53,765 volume. The average volume for the last 3 months is 212,670 and the stock's 52-week low/high is $0.1498/$0.3756.
Recent News
- Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF) - NetworkNewsBreaks - Nicola Mining Inc. (TSX.V: NIM) (FSE: HLIA) (OTCQB: HUSIF) CEO Highlights Cash Flow and Copper Growth on MiningNewsWire Podcast
- MiningNewsBreaks - Nicola Mining Inc. (TSXV: NIM) (FSE: HLIA) (OTCQB: HUSIF) Secures Multi-Year Exploration Permit for Treasure Mountain Silver Project
- RockBreaks - Nicola Mining Inc. (TSX.V: NIM) (FSE: HLIA) (OTCQB: HUSIF) Strengthens Copper Exploration Team with Senior Geologist Hire
The QualityStocks Numbers Report
The QualityStocks Sponsored News
- 180 Life Sciences Corp. (NASDAQ: ATNF) - 180 Life Sciences Corp. Announces Notice of Allowance for U.S. Patent Covering Novel Method to Prevent or Reduce Post-Operative Cognitive Dysfunction
- Adageis - Adageis Allows Healthcare Providers Maximum Value-Based Care Revenue with Simplicity and Visibility
- Aditxt Inc. (NASDAQ: ADTX) - BioMedNewsBreaks - Aditxt Inc. (NASDAQ: ADTX) Terminates Acquisition Agreement with Appili Therapeutics
- Amesite Inc. (NASDAQ: AMST) - Amesite Announces Successful Launch of New, Higher-Priced Tier of Service in Response to B2B Demand
- Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) - Appia Announces That Stephen Burega is Leaving the Company
- Annovis Bio Inc. (NYSE: ANVS) - BioMedNewsBreaks - Annovis Bio Inc. (NYSE: ANVS) to Host Webcast With CEO to Share Updates on Alzheimer's and Parkinson's Programs
- Astiva Health - More American Doctors are Relocating to Canada, Citing Federal Government Issues
- Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF) - Arizona Metals Intersects 34.8 m @ 11.3 g/t AuEq in Kay2 Zone
- Astrotech Corp. (NASDAQ: ASTC) - 1st Detect Unveils Enhanced TRACER 1000 Narcotics Trace Detector Intended to Combat Synthetic Opiates and Novel Psychoactive Substances
- Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) - Copper Supply Disparities Grow as More Shipments Head to the US
- Augmedix Inc. (NASDAQ: AUGX) - Augmedix Partners with Google Cloud to Bring Medically-Tuned AI Technology to Ambient Documentation
- Beeline Holdings Inc. (NASDAQ: BLNE) - AINewsBreaks - Beeline Holdings, Inc. (NASDAQ: BLNE) Unveils Blockchain-Linked Equity Solution to Bypass Interest Rates
- BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) - InvestorNewsBreaks - BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Releases Shareholder Update with Corporate, Operational Highlights
- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) - BioMedNewsBreaks - Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Receives Italian Clearance for Option to Acquire Biotech Firm Pincell
- Bravo Multinational Inc. (OTC: BRVO) - InvestorNewsBreaks - Bravo Multinational Inc. (OTC: BRVO) Unveils First Charitable Mobile Service
- BioNxt Solutions Inc. (CSE: BNXT) (OTCQB: BNXTF) (FSE: 4XT) - BioNxt Solutions Reports Expanded Patent Protection from the Eurasian Patent Organization
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) - Blue Hat Interactive Entertainment Technology 2024 Financial Results Report: Total Assets Surge by 53%
- Btab Ecommerce Group Inc. (OTC: BBTT) - Integrated Wellness Acquisition Corp. and Btab Ecommerce Group, Inc. Announce Filing of Draft Registration Statement on Form S-4 with the SEC
- Brera Holdings PLC (NASDAQ: BREA) - NetworkNewsBreaks - Brera Holdings PLC (NASDAQ: BREA) Forms Strategic Alliance with Toronto Blizzard to Develop Global Soccer Talent Pipeline
- Calidi Biotherapeutics Inc. (NYSE American: CLDI) - TinyGemsBreaks - Calidi Biotherapeutics Inc. (NYSE American: CLDI) Taps Biotech Veteran to Lead Next Phase of Growth
- Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) - Canada Nickel Secures US$20 Million Bridge Loan Facilitated by BT Capital and Provides Corporate Update
- CISO Global, Inc. (NASDAQ: CISO) - CISO Global brings AI to $50 Billion Insurance Market with Cyber Assurance Group Strategic Partnership to Deliver Innovative Cyber Technology and Insurance Solutions
- Clene Inc. (NASDAQ: CLNN) - Study Finds Kids with MS Biologically Age Faster Than Those Without It
- CNS Pharmaceuticals Inc. (NASDAQ: CNSP) - BioMedNewsBreaks - CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present Promising Glioblastoma Data at Brain Tumor Biotech Summit
- Correlate Energy Corp. (OTCQB: CIPI) - GreenEnergyBreaks - Correlate Energy Corp. (CIPI) Facilitating Global Transition Toward Solar
- Coyuchi Inc. - InvestorNewsBreaks – Coyuchi Inc. Pushing Organic Textile Market Forward Through Its Circular Initiatives
- Cub Crafters Inc. - InvestorNewsBreaks – CubCrafters Inc. Eyes Increase in Stock Price
- Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) - InvestorNewsBreaks - Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Highlights Progress on Phase 3 Psychedelic Therapeutics Program
- DarioHealth Corp. (NASDAQ: DRIO) - Dario's Digital Health Solution Demonstrates Effectiveness in New Research Examining Flu Vaccination Awareness in High-Risk Populations
- Diamond Lake Minerals Inc. (OTC: DLMI) - Diamond Lake Minerals Launches Advanced Materials & IP Division and Files Inaugural Provisional Patent for Physics-Informed Valuation Technology
- Data443 Risk Mitigation Inc. (OTC: ATDS) - Data443 Completes Operational Expense Rationalization
- D-Wave Quantum Inc. (NYSE: QBTS) - TechMediaBreaks - D-Wave Quantum Inc. (NYSE: QBTS) Signs MOU to Advance Quantum Computing in South Korea
- ECGI Holdings Inc. (OTC: ECGI) - InvestorNewsBreaks - ECGI Holdings Inc. (OTC: ECGI) Invests in AI-Driven Fantasy Sports Platform Payday Fantasy
- Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) - Eloro Resources Announces Closing of $2.5 Million Non-Brokered Private Placement
- Emperor Metals Inc. (CSE: AUOZ) (FRA:9NH) (OTCQB: EMAUF) - InvestorNewsBreaks - Emperor Metals Inc. (CSE: AUOZ) (OTCQB: EMAUF) (FRA:9NH) to Attend Tier I Mining Conference in Québec City
- Energy and Water Development Corp. (OTCQB: EAWD) - Data Officers and the Crucial Role They Play in ESG Accountability
- Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) - BillionDollarBreaks - Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Elects Board, Names Bruce Hansen as New Chair
- EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) - EverGen Infrastructure Reports Q4 & Year End 2024 Results
- ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) - RockBreaks - ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Launches $3.3 Million Private Placement to Advance Montauban Project
- Exro Technologies Inc. (TSX: EXRO) (OTCQB: EXROF) - Exro Technologies Responds to Market Activity
- FingerMotion Inc. (NASDAQ: FNGR) - ChineseNewsBreaks - FingerMotion Inc. (NASDAQ: FNGR) Subsidiary JiuGe Forms Strategic Alliance for Emergency Response Vehicles
- First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) - InvestorNewsBreaks - First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) Successfully Road-Tests Thermoelectric Generator Radiator
- Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) - RockBreaks - Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Expands Gochager Lake Property, Postpones Field Program Due to Saskatchewan Wildfires
- Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) - BillionDollarBreaks - Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Elects Board, Names Bruce Hansen as New Chair
- FE Battery Metals Corp. (CSE: FE) (OTCQB: FEMFF) - InvestorNewsBreaks - FE Battery Metals Corp. (CSE: FE) (OTCQB: FEMFF) (WKN: A2JC89) Announces Proposed $1M Non-Brokered Private Placement
- Flora Growth Corp. (NASDAQ: FLGC) - InvestorNewsBreaks - Flora Growth Corp. (NASDAQ: FLGC) Closes $3.6M Registered Direct
- Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) - InvestorNewsBreaks - Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) Secures Permit for Athabasca Basin Uranium Exploration
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) - InvestorNewsBreaks - Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), BuilderX Partner to Integrate Advanced 3D Perception Technology into Heavy Machinery
- Fresh2 Group Ltd. (NASDAQ: FRES) - Appointment of New Independent Director
- Freight Technologies Inc. (NASDAQ: FRGT) - TechMediaBreaks - Freight Technologies Inc. (NASDAQ: FRGT) Moves to Advance Digital Asset Strategy
- Gaxos.ai Inc. (NASDAQ: GXAI) - TechMediaBreaks - Gaxos.ai Inc. (NASDAQ: GXAI) Launches UnGPT.ai to Transform AI-Generated Text into Humanlike Content
- GEMXX Corp. (OTC: GEMZ) - The Oil, Gas Sector is Already Feeling the Effects of the Israel-Iran Conflict
- GeoSolar Technologies Inc. - QualityStocksNewsBreaks – GeoSolar Technologies Inc. Taking Part in Shift Toward a Greener Future
- Global Compliance Applications Corp. (CSE: APP) (OTCQB: FUAPF) - InvestorNewsBreaks - Global Compliance Applications Corp. (CSE: APP) (OTC: FUAPF) (FSE: 2FA), EMTRI Corp. Scale Services in California's Booming Cannabis Market
- GivBux Inc. (OTC: GBUX) - TechMediaBreaks - GivBux Inc. (OTC: GBUX) Finalizes Deal to Acquire Charter House, Refocuses on Gold-Backed Fintech Expansion
- Golden Matrix Group Inc. (NASDAQ: GMGI) - InvestorNewsBreaks - Golden Matrix Group Inc. (NASDAQ: GMGI) CEO to Present at the Upcoming 17th Annual LD Micro Main Event
- SportLync Inc. - SportLync Outlines 2025 Roadmap, with Expanded Sports Offerings and Enhanced User Experiences
- Greenwave Technology Solutions Inc. (NASDAQ: GWAV) - TechMediaBreaks - Greenwave Technology Solutions Inc. (NASDAQ: GWAV) Sees Margin Growth as Scrap Steel Prices Surge
- RYVYL Inc. (NASDAQ: RVYL) - InvestorNewsBreaks - RYVYL Inc. (NASDAQ: RVYL) to Participate at Upcoming LD Micro Main Event XVII
- HeartBeam Inc. (NASDAQ: BEAT) - InvestorNewsBreaks - HeartBeam Inc. (NASDAQ: BEAT) Secures Two New Patents Advancing 3D ECG and Cardiac Monitoring Technology
- HealthLynked Corp. (OTCQB: HLYK) - BioMedNewsBreaks - HealthLynked Corp. (HLYK) Launches Upgrade to Empower Patients, Drive Better Outcomes
- Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTD) (FRA: 7HIA.F) - InvestorNewsBreaks - Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F) CEO Featured in Latest Episode of MarketGems Podcast
- Horizon Fintex | Upstream - InvestorNewsBreaks – Upstream Enhances KYC Process to Streamline User Experience
- IGC Pharma Inc. (NYSE American: IGC) - InvestorNewsBreaks - IGC Pharma Inc. (NYSE American: IGC) Advances IGC-AD1 Research to Potentially Deliver 'Breakthrough Treatment' in Alzheimer's Disease
- Infobird Co., Ltd (NASDAQ: IFBD) - InvestorNewsBreaks - Infobird Co. Ltd. (NASDAQ: IFBD) Announces Delayed Effective Date of Reverse Split
- InMed Pharmaceuticals Inc. (NASDAQ: INM) - InvestorNewsBreaks - InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Fiscal 2024 Financial Results, Provides Business Update
- Intelligent Bio Solutions Inc. (NASDAQ: INBS) - BioMedNewsBreaks - Intelligent Bio Solutions Inc. (NASDAQ: INBS) to Deploy Fingerprint Drug Testing System Across MWS Sites in Australia
- Safety Shot Inc. (NASDAQ: SHOT) - InvestorNewsBreaks - Safety Shot (NASDAQ: SHOT) Launches Rebrand Featuring New Name, New Look, New Packaging
- BlockQuarry Corp. (OTC: BLQC) - InvestorNewsBreaks - BlockQuarry Corp. (BLQC) Completes 'Key Steps' in Long-Term Vision to Strengthen Position as an Innovator in Healthcare Solutions
- Kairos Pharma Ltd. (NYSE American: KAPA) - InvestorNewsBreaks - Kairos Pharma Ltd. (NYSE American: KAPA) Highlights Positive Preclinical Data for KROS101 at ASCO 2025
- Knightscope (NASDAQ: KSCP) - InvestorNewsBreaks - Knightscope, Inc. (NASDAQ: KSCP) Secures Over $1 Million in Contracts Including New ASR and ECD Deployments
- LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) - LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Is 'One to Watch'
- Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) - RockBreaks - Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Gains BLM Approval for Expanded Drilling at Santa Fe Mine
- Lantern Pharma Inc. (NASDAQ: LTRN) - InvestorNewsBreaks - Lantern Pharma Inc. (NASDAQ: LTRN) Reports Complete Response in Advanced NSCLC Patient in HARMONIC(TM) Trial
- Laredo Oil Inc. (OTC: LRDC) - InvestorNewsBreaks - Laredo Oil Inc. (LRDC) Announces Entry into Common Stock Purchase Agreements with Gross Proceeds of $750K
- Longeveron Inc. (NASDAQ: LGVN) - InvestorNewsBreaks - Longeveron Inc. (NASDAQ: LGVN) to Present 'Important' Lomecel-B(TM) Data at the 17th Clinical Trials on Alzheimer's Disease Conference
- Lexaria Bioscience Corp. (NASDAQ: LEXX) - InvestorNewsBreaks - Lexaria Bioscience Corp. (NASDAQ: LEXX) Highlights Expanding Opportunities in GLP-1 Drug Market and Strategic Focus on DehydraTECH Integration
- Life Electric Vehicles Holdings Inc. (OTC: LFEV) - Why Trump May Be Unlikely to Stop Public EV Charger Construction
- Lottery.com Inc. (NASDAQ: LTRY) - InvestorNewsBreaks - Lottery.com Inc.'s (NASDAQ: LTRY) Sports.com Achieves Major Milestone in Its Global Expansion
- LQwD Technologies Corp. (TSX.V: LQWD) (OTCQB: LQWDF) - InvestorNewsBreaks - LQWD Technologies Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Announces Record Transaction Growth, No. 1 Ranking on Lightning Terminal
- Massimo Group (NASDAQ: MAMO) - Electric Vehicle Sales are Rebounding in Europe
- McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) - MiningNewsBreaks - McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Begins Construction on Stock Mine Ramp to Lower Costs and Boost Gold Output
- Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) - MIND CURE HEALTH INC. ANNOUNCES CLOSING OF THE FIRST TRANCHE OF LNG ENERGY GROUP'S SUBSCRIPTION RECEIPT FINANCING
- Mydecine Innovations Group Inc. (NEO: MYCO) (FSE: 0NFA) (OTC: MYCOF) - InvestorNewsBreaks - Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Board Approves Issuance of Shares for Debt Settlement
- NanoViricides Inc. (NYSE American: NNVC) - InvestorNewsBreaks - NanoViricides (NYSE American: NNVC) Highlights NV-387 as Broad-Spectrum Antiviral Candidate for COVID and Bird Flu Preparedness
- Newton Golf Company Inc. (NASDAQ: NWTG) - InvestorNewsBreaks - Newton Golf Company Inc. (NASDAQ: NWTG) Signs Miguel Ángel Jiménez Following Victory with Fast Motion Shaft
- NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW) - TinyGemsBreaks - NextPlat Corp. (NASDAQ: NXPL) Announces Passing of CEO Charles M. Fernandez, Appoints Interim Leadership
- Nightfood Holdings Inc. (OTCQB: NGTF) - Smart Hospitality: SkyTech Robots and the Future of U.S. Service Innovation Through AI
- Nowigence Inc. (OTCQB: NOWG) - Nowigence Inc. (NOWG) Starts Trading on OTC
- NRx Pharmaceuticals Inc. (NASDAQ: NRXP) - BioMedNewsBreaks - NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Forms Investor Relations Partnership With astr Partners
- Nutriband Inc. (NASDAQ: NTRB) - BioMedNewsBreaks - Nutriband Inc. (NASDAQ: NTRB) Advances Aversa Fentanyl with Kindeva to Commercial Manufacturing Scale
- Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF) - NetworkNewsBreaks - Nicola Mining Inc. (TSX.V: NIM) (FSE: HLIA) (OTCQB: HUSIF) CEO Highlights Cash Flow and Copper Growth on MiningNewsWire Podcast
- OK Stone Engineering Inc. - InvestorNewsBreaks — OK Stone Engineering Partners with Oren Klaff at Special Investor Event
- Oragenics Inc. (NYSE American: OGEN) - InvestorNewsBreaks - Oragenics Inc. (NYSE American: OGEN) to Spotlight Concussion Candidate at BIO 2025 and Neurotrauma Symposium
- Mullen Automotive Inc. (NASDAQ: MULN) - Trump Signs Measure Overriding EV Mandate, a Blow to Musk and California
- ONAR Holding Corp. (OTCQB: ONAR) - ONAR Holding Corp. (ONAR) Takes the Lead in AI-Driven Marketing as CEO Shares Vision
- PaxMedica Inc. (NASDAQ: PXMD) - Kids with Autism are Less Prone to Severe Injuries Compared to Those with ADHD
- Platinum Group Metals Ltd. (TSX: PTM) (NYSE American: PLG) - Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Advances Waterberg Project Amid Third Straight Year of Platinum Deficits
- Playgon Games Inc. (TSX.V: DEAL) (OTC: PLGNF) - InvestorNewsBreaks - Playgon Games Inc. (TSX.V: DEAL) (OTC: PLGNF) (FSE: 7CR) Receives Recognition for 'Pushing the Boundaries of Live Dealer Gaming'
- Predictive Oncology (NASDAQ: POAI) - InvestorNewsBreaks - Predictive Oncology Inc. (NASDAQ: POAI) Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference
- Processa Pharmaceuticals Inc. (NASDAQ: PCSA) - InvestorNewsBreaks - Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Participate at the H.C. Wainwright 26th Annual Global Investment Conference, ESMO Congress 2024
- Progressive Care Inc. (OTCQB: RXMD) - InvestorNewsBreaks - Progressive Care Inc. (RXMD) Releases Q1 2024 Financial Report Showing Record Revenue
- Prospera Energy Inc. (TSX.V: PEI) (FRA: OF6B) (OTC: GXRFF) - InvestorNewsBreaks - Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) Announces 17% Working Interest Increase in Its Core Heavy Oil Properties
- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) - InvestorNewsBreaks - Quantum BioPharma Ltd. (NASDAQ: QNTM) Advances Brain and Alcohol Health Pipeline, Receives Phase 2 Trial Approval for FSD202
- Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) - InvestorNewsBreaks - Red White & Bloom Brands Inc. (CSE: RWB) Releases Q2 2024 Financial Report, Business Update
- Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) - IEA Review: 2024 Electricity Demand Surge Boosted Both Fossil Fuels and Renewables
- Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) - InvestorNewsBreaks - Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) (FSE: 9RR) Highlights Exploration Strategy and Growth Potential on The Bell2Bell Podcast
- G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) - InvestorNewsBreaks - G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) Files NI 43-101 Technical Report for Oko West Feasibility Study
- REZYFi, Inc. - InvestorNewsBreaks – REZYFi Inc. Using Diversified Approach to Capitalize on Growth in Multiple Verticals
- N2OFF Inc. (NASDAQ: NITO) - InvestorNewsBreaks - N2OFF Inc.'s (NASDAQ: NITO) (FSE: 80W) Subsidiary Enters LOI with Ethiopian Federal Agency to Support Transition to Sustainable Farming Practices
- Software Effective Solutions Corp. (OTC: SFWJ) - InvestorNewsBreaks - Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) Cancels and Swaps Over 88M Shares to Reduce Outstanding Share Count
- SolarBank Corp. (Cboe CA: SUNN) (FSE: GY2) (NASDAQ: SUUN) - California to Fast-Track Largest Project for Battery Energy Storage
- Soligenix Inc. (NASDAQ: SNGX) - Soligenix Inc. (NASDAQ: SNGX) Proprietary Therapy Shows Promise in Treatment of Psoriasis
- Sigyn Therapeutics Inc. (OTCQB: SIGY) - BioMedNewsBreaks - Sigyn Therapeutics Inc. (SIGY) Leveraging Portfolio to Overcome Current Limitations in Healthcare
- Silo Pharma Inc. (OTCQB: SILO) - PsychedelicNewsBreaks - Silo Pharma Inc. (NASDAQ: SILO) Receives USPTO Notice of Allowance for PTSD Treatment Patent
- Silvercorp Metals Inc. (NYSE American: SVM) (TSX: SVM) - InvestorNewsBreaks - Silvercorp Metals Inc. (TSX: SVM) (NYSE American: SVM) Files Updated Resource Estimate for Condor Gold Project in Ecuador
- SuperCom Ltd. (NASDAQ: SPCB) - SuperCom Ltd. (NASDAQ: SPCB) Continues Expansion of National Public Safety EM Contracts
- Siyata Mobile Inc. (NASDAQ: SYTA) - InvestorNewsBreaks - Siyata Mobile Inc. (NASDAQ: SYTA) to Attend Two Upcoming Industry Events
- SOBRsafe Inc. (NASDAQ: SOBR) - TechMediaBreaks - SOBRsafe Inc. (NASDAQ: SOBR) Reports 80.5% Revenue Growth and Improved Margins in Q1 2025
- Solowin Holdings (NASDAQ: SWIN) - Solowin Holdings (NASDAQ: SWIN) Is 'One to Watch'
- Splash Beverage Group Inc. (NYSE American: SBEV) - InvestorNewsBreaks - Splash Beverage Group, Inc. (NYSE American: SBEV) Revises Terms for Western Son Vodka Acquisition
- Standard Lithium Ltd. (NYSE American: SLI) - InvestorNewsBreaks - Standard Lithium Ltd. (NYSE American: SLI) Produces Battery-Grade Lithium Sulfide in Collaboration with Telescope Innovations
- Starco Brands Inc. (OTCQB: STCB) - InvestorNewsBreaks - Starco Brands Inc. (STCB), DoorDash Collaborate in Special Autumn Whipshots Offer
- StorEn Technologies Inc. - InvestorNewsBreaks – StorEn Technologies Inc. Recognized for Bringing Real Innovation to Vanadium Flow Batteries
- Vision Marine Technologies Inc. (NASDAQ: VMAR) - InvestorNewsBreaks - Vision Marine Technologies Inc. (NASDAQ: VMAR) Unveils Market's Most Efficient, Powerful Inboard Electric Motor System
- SenesTech Inc. (NASDAQ: SNES) - InvestorNewsBreaks - SenesTech Inc. (NASDAQ: SNES) Reports 51% Revenue Increase in Q3 2024, Highlights Growth in Evolve Product Line and International Expansion
- Sekur Private Data Ltd. (FRA: GDT0) (CSE: SKUR) (OTCQB: SWISF) - TechMediaBreaks - Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0) Launches D.C.-Based Division to Protect Diplomats from Escalating Cyber Threats
- TAAT Global Alternatives Inc. (CSE: TAAT) (FRANKFURT: 2TP) (OTCQX: TOBAF) - InvestorNewsBreaks - TAAT(TM) Global Alternatives Inc. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) Plans 10-to-One Share Consolidation
- Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF) - InvestorNewsBreaks - Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF) (FSE: 8TA) Names Seasoned Veteran as New Director
- Telomir Pharmaceuticals Inc. (NASDAQ: TELO) - BioMedNewsBreaks - Telomir Pharmaceuticals (NASDAQ: TELO) Reports Preclinical Success for Telomir-1 in Progeria Cell Lines
- Thumzup Media Corp. (NASDAQ: TZUP) - England OKs Teachers' Use of AI While Marking Students' Work
- Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) - InvestorNewsBreaks - Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Presents Positive Phase 3 Data on Fibromyalgia Drug at EULAR 2025
- Torr Metals Inc. (TSX.V: TMET) - Peru Acknowledges the Existence of Widespread Artisanal Copper Mining
- TransCode Therapeutics Inc. (NASDAQ: RNAZ) - InvestorNewsBreaks - TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Appoints RNAi Pioneer Phillip Zamore to Scientific Advisory Board
- Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) - MiningNewsBreaks - Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) Settles $101K Debt with Share Issuance Including Insider Participation
- Turbo Energy S.A. (NASDAQ: TURB) - InvestorNewsBreaks - Turbo Energy S.A. (NASDAQ: TURB) Shareholders Approve Key Proposals at Extraordinary General Meeting
- Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) - MiningNewsBreaks - Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Closes Oversubscribed Private Placement for Strategic Metals Complex Development
- Uranium Energy Corp. (NYSE American: UEC) - InvestorNewsBreaks - Uranium Energy Corp. (NYSE American: UEC) Ramps Up U.S. Production as Nuclear Demand Surges
- VistaGen Therapeutics Inc. (NASDAQ: VTGN) - InvestorNewsBreaks - Vistagen Therapeutics Inc. (NASDAQ: VTGN) Announces Joint Ceremony to Ring Nasdaq Closing Bell in Honor of World Mental Health Day
- Vivakor Inc. (NASDAQ: VIVK) - InvestorNewsBreaks - Why Vivakor Inc. (NASDAQ: VIVK) Is 'One to Watch'
- Vivos Therapeutics Inc. (NASDAQ: VVOS) - InvestorNewsBreaks - Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces AMA Issues CPT Codes, Coverage for Vivos CARE Oral Medical Devices
- Datavault AI Inc. (NASDAQ: DVLT) - InvestorNewsBreaks - Datavault AI Inc. (NASDAQ: DVLT) and GFT Rewards Partner to Deliver ADIO(R)-Powered Web3 Mobile Incentives
- Wheaton Precious Metals Corp. (TSX: WPM) (NYSE: WPM) - InvestorNewsBreaks - Wheaton Precious Metals Corp. (NYSE: WPM) (TSX: WPM) Releases 2024 Sustainability and Climate Change Reports Highlighting ESG Progress
- Wrap Technologies Inc. (NASDAQ: WRAP) - Wrap Technologies, Inc. Bolsters BolaWrap® 150 Deployments, Promoting Safer Communities Nationwide
- Zoned Properties Inc. (ZDPY) - InvestorNewsBreaks - Zoned Properties Inc. (ZDPY) Releases Q2 2024 Financial Results, Operations Report
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- 180 Life Sciences Corp. (NASDAQ: ATNF) - 180 Life Sciences Corp. Announces Notice of Allowance for U.S. Patent Covering Novel Method to Prevent or Reduce Post-Operative Cognitive Dysfunction
- Adageis - Adageis Allows Healthcare Providers Maximum Value-Based Care Revenue with Simplicity and Visibility
- Aditxt Inc. (NASDAQ: ADTX) - BioMedNewsBreaks - Aditxt Inc. (NASDAQ: ADTX) Terminates Acquisition Agreement with Appili Therapeutics
- Amesite Inc. (NASDAQ: AMST) - Amesite Announces Successful Launch of New, Higher-Priced Tier of Service in Response to B2B Demand
- Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) - Appia Announces That Stephen Burega is Leaving the Company
- Annovis Bio Inc. (NYSE: ANVS) - BioMedNewsBreaks - Annovis Bio Inc. (NYSE: ANVS) to Host Webcast With CEO to Share Updates on Alzheimer's and Parkinson's Programs
- Astiva Health - More American Doctors are Relocating to Canada, Citing Federal Government Issues
- Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF) - Arizona Metals Intersects 34.8 m @ 11.3 g/t AuEq in Kay2 Zone
- Astrotech Corp. (NASDAQ: ASTC) - 1st Detect Unveils Enhanced TRACER 1000 Narcotics Trace Detector Intended to Combat Synthetic Opiates and Novel Psychoactive Substances
- Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) - Copper Supply Disparities Grow as More Shipments Head to the US
- Augmedix Inc. (NASDAQ: AUGX) - Augmedix Partners with Google Cloud to Bring Medically-Tuned AI Technology to Ambient Documentation
- Beeline Holdings Inc. (NASDAQ: BLNE) - AINewsBreaks - Beeline Holdings, Inc. (NASDAQ: BLNE) Unveils Blockchain-Linked Equity Solution to Bypass Interest Rates
- BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) - InvestorNewsBreaks - BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Releases Shareholder Update with Corporate, Operational Highlights
- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) - BioMedNewsBreaks - Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Receives Italian Clearance for Option to Acquire Biotech Firm Pincell
- Bravo Multinational Inc. (OTC: BRVO) - InvestorNewsBreaks - Bravo Multinational Inc. (OTC: BRVO) Unveils First Charitable Mobile Service
- BioNxt Solutions Inc. (CSE: BNXT) (OTCQB: BNXTF) (FSE: 4XT) - BioNxt Solutions Reports Expanded Patent Protection from the Eurasian Patent Organization
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) - Blue Hat Interactive Entertainment Technology 2024 Financial Results Report: Total Assets Surge by 53%
- Btab Ecommerce Group Inc. (OTC: BBTT) - Integrated Wellness Acquisition Corp. and Btab Ecommerce Group, Inc. Announce Filing of Draft Registration Statement on Form S-4 with the SEC
- Brera Holdings PLC (NASDAQ: BREA) - NetworkNewsBreaks - Brera Holdings PLC (NASDAQ: BREA) Forms Strategic Alliance with Toronto Blizzard to Develop Global Soccer Talent Pipeline
- Calidi Biotherapeutics Inc. (NYSE American: CLDI) - TinyGemsBreaks - Calidi Biotherapeutics Inc. (NYSE American: CLDI) Taps Biotech Veteran to Lead Next Phase of Growth
- Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) - Canada Nickel Secures US$20 Million Bridge Loan Facilitated by BT Capital and Provides Corporate Update
- CISO Global, Inc. (NASDAQ: CISO) - CISO Global brings AI to $50 Billion Insurance Market with Cyber Assurance Group Strategic Partnership to Deliver Innovative Cyber Technology and Insurance Solutions
- Clene Inc. (NASDAQ: CLNN) - Study Finds Kids with MS Biologically Age Faster Than Those Without It
- CNS Pharmaceuticals Inc. (NASDAQ: CNSP) - BioMedNewsBreaks - CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present Promising Glioblastoma Data at Brain Tumor Biotech Summit
- Correlate Energy Corp. (OTCQB: CIPI) - GreenEnergyBreaks - Correlate Energy Corp. (CIPI) Facilitating Global Transition Toward Solar
- Coyuchi Inc. - InvestorNewsBreaks – Coyuchi Inc. Pushing Organic Textile Market Forward Through Its Circular Initiatives
- Cub Crafters Inc. - InvestorNewsBreaks – CubCrafters Inc. Eyes Increase in Stock Price
- Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) - InvestorNewsBreaks - Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Highlights Progress on Phase 3 Psychedelic Therapeutics Program
- DarioHealth Corp. (NASDAQ: DRIO) - Dario's Digital Health Solution Demonstrates Effectiveness in New Research Examining Flu Vaccination Awareness in High-Risk Populations
- Diamond Lake Minerals Inc. (OTC: DLMI) - Diamond Lake Minerals Launches Advanced Materials & IP Division and Files Inaugural Provisional Patent for Physics-Informed Valuation Technology
- Data443 Risk Mitigation Inc. (OTC: ATDS) - Data443 Completes Operational Expense Rationalization
- D-Wave Quantum Inc. (NYSE: QBTS) - TechMediaBreaks - D-Wave Quantum Inc. (NYSE: QBTS) Signs MOU to Advance Quantum Computing in South Korea
- ECGI Holdings Inc. (OTC: ECGI) - InvestorNewsBreaks - ECGI Holdings Inc. (OTC: ECGI) Invests in AI-Driven Fantasy Sports Platform Payday Fantasy
- Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) - Eloro Resources Announces Closing of $2.5 Million Non-Brokered Private Placement
- Emperor Metals Inc. (CSE: AUOZ) (FRA:9NH) (OTCQB: EMAUF) - InvestorNewsBreaks - Emperor Metals Inc. (CSE: AUOZ) (OTCQB: EMAUF) (FRA:9NH) to Attend Tier I Mining Conference in Québec City
- Energy and Water Development Corp. (OTCQB: EAWD) - Data Officers and the Crucial Role They Play in ESG Accountability
- Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) - BillionDollarBreaks - Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Elects Board, Names Bruce Hansen as New Chair
- EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) - EverGen Infrastructure Reports Q4 & Year End 2024 Results
- ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) - RockBreaks - ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Launches $3.3 Million Private Placement to Advance Montauban Project
- Exro Technologies Inc. (TSX: EXRO) (OTCQB: EXROF) - Exro Technologies Responds to Market Activity
- FingerMotion Inc. (NASDAQ: FNGR) - ChineseNewsBreaks - FingerMotion Inc. (NASDAQ: FNGR) Subsidiary JiuGe Forms Strategic Alliance for Emergency Response Vehicles
- First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) - InvestorNewsBreaks - First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) Successfully Road-Tests Thermoelectric Generator Radiator
- Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) - RockBreaks - Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Expands Gochager Lake Property, Postpones Field Program Due to Saskatchewan Wildfires
- Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) - BillionDollarBreaks - Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Elects Board, Names Bruce Hansen as New Chair
- FE Battery Metals Corp. (CSE: FE) (OTCQB: FEMFF) - InvestorNewsBreaks - FE Battery Metals Corp. (CSE: FE) (OTCQB: FEMFF) (WKN: A2JC89) Announces Proposed $1M Non-Brokered Private Placement
- Flora Growth Corp. (NASDAQ: FLGC) - InvestorNewsBreaks - Flora Growth Corp. (NASDAQ: FLGC) Closes $3.6M Registered Direct
- Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) - InvestorNewsBreaks - Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) Secures Permit for Athabasca Basin Uranium Exploration
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) - InvestorNewsBreaks - Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), BuilderX Partner to Integrate Advanced 3D Perception Technology into Heavy Machinery
- Fresh2 Group Ltd. (NASDAQ: FRES) - Appointment of New Independent Director
- Freight Technologies Inc. (NASDAQ: FRGT) - TechMediaBreaks - Freight Technologies Inc. (NASDAQ: FRGT) Moves to Advance Digital Asset Strategy
- Gaxos.ai Inc. (NASDAQ: GXAI) - TechMediaBreaks - Gaxos.ai Inc. (NASDAQ: GXAI) Launches UnGPT.ai to Transform AI-Generated Text into Humanlike Content
- GEMXX Corp. (OTC: GEMZ) - The Oil, Gas Sector is Already Feeling the Effects of the Israel-Iran Conflict
- GeoSolar Technologies Inc. - QualityStocksNewsBreaks – GeoSolar Technologies Inc. Taking Part in Shift Toward a Greener Future
- Global Compliance Applications Corp. (CSE: APP) (OTCQB: FUAPF) - InvestorNewsBreaks - Global Compliance Applications Corp. (CSE: APP) (OTC: FUAPF) (FSE: 2FA), EMTRI Corp. Scale Services in California's Booming Cannabis Market
- GivBux Inc. (OTC: GBUX) - TechMediaBreaks - GivBux Inc. (OTC: GBUX) Finalizes Deal to Acquire Charter House, Refocuses on Gold-Backed Fintech Expansion
- Golden Matrix Group Inc. (NASDAQ: GMGI) - InvestorNewsBreaks - Golden Matrix Group Inc. (NASDAQ: GMGI) CEO to Present at the Upcoming 17th Annual LD Micro Main Event
- SportLync Inc. - SportLync Outlines 2025 Roadmap, with Expanded Sports Offerings and Enhanced User Experiences
- Greenwave Technology Solutions Inc. (NASDAQ: GWAV) - TechMediaBreaks - Greenwave Technology Solutions Inc. (NASDAQ: GWAV) Sees Margin Growth as Scrap Steel Prices Surge
- RYVYL Inc. (NASDAQ: RVYL) - InvestorNewsBreaks - RYVYL Inc. (NASDAQ: RVYL) to Participate at Upcoming LD Micro Main Event XVII
- HeartBeam Inc. (NASDAQ: BEAT) - InvestorNewsBreaks - HeartBeam Inc. (NASDAQ: BEAT) Secures Two New Patents Advancing 3D ECG and Cardiac Monitoring Technology
- HealthLynked Corp. (OTCQB: HLYK) - BioMedNewsBreaks - HealthLynked Corp. (HLYK) Launches Upgrade to Empower Patients, Drive Better Outcomes
- Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTD) (FRA: 7HIA.F) - InvestorNewsBreaks - Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F) CEO Featured in Latest Episode of MarketGems Podcast
- Horizon Fintex | Upstream - InvestorNewsBreaks – Upstream Enhances KYC Process to Streamline User Experience
- IGC Pharma Inc. (NYSE American: IGC) - InvestorNewsBreaks - IGC Pharma Inc. (NYSE American: IGC) Advances IGC-AD1 Research to Potentially Deliver 'Breakthrough Treatment' in Alzheimer's Disease
- Infobird Co., Ltd (NASDAQ: IFBD) - InvestorNewsBreaks - Infobird Co. Ltd. (NASDAQ: IFBD) Announces Delayed Effective Date of Reverse Split
- InMed Pharmaceuticals Inc. (NASDAQ: INM) - InvestorNewsBreaks - InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Fiscal 2024 Financial Results, Provides Business Update
- Intelligent Bio Solutions Inc. (NASDAQ: INBS) - BioMedNewsBreaks - Intelligent Bio Solutions Inc. (NASDAQ: INBS) to Deploy Fingerprint Drug Testing System Across MWS Sites in Australia
- Safety Shot Inc. (NASDAQ: SHOT) - InvestorNewsBreaks - Safety Shot (NASDAQ: SHOT) Launches Rebrand Featuring New Name, New Look, New Packaging
- BlockQuarry Corp. (OTC: BLQC) - InvestorNewsBreaks - BlockQuarry Corp. (BLQC) Completes 'Key Steps' in Long-Term Vision to Strengthen Position as an Innovator in Healthcare Solutions
- Kairos Pharma Ltd. (NYSE American: KAPA) - InvestorNewsBreaks - Kairos Pharma Ltd. (NYSE American: KAPA) Highlights Positive Preclinical Data for KROS101 at ASCO 2025
- Knightscope (NASDAQ: KSCP) - InvestorNewsBreaks - Knightscope, Inc. (NASDAQ: KSCP) Secures Over $1 Million in Contracts Including New ASR and ECD Deployments
- LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) - LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Is 'One to Watch'
- Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) - RockBreaks - Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Gains BLM Approval for Expanded Drilling at Santa Fe Mine
- Lantern Pharma Inc. (NASDAQ: LTRN) - InvestorNewsBreaks - Lantern Pharma Inc. (NASDAQ: LTRN) Reports Complete Response in Advanced NSCLC Patient in HARMONIC(TM) Trial
- Laredo Oil Inc. (OTC: LRDC) - InvestorNewsBreaks - Laredo Oil Inc. (LRDC) Announces Entry into Common Stock Purchase Agreements with Gross Proceeds of $750K
- Longeveron Inc. (NASDAQ: LGVN) - InvestorNewsBreaks - Longeveron Inc. (NASDAQ: LGVN) to Present 'Important' Lomecel-B(TM) Data at the 17th Clinical Trials on Alzheimer's Disease Conference
- Lexaria Bioscience Corp. (NASDAQ: LEXX) - InvestorNewsBreaks - Lexaria Bioscience Corp. (NASDAQ: LEXX) Highlights Expanding Opportunities in GLP-1 Drug Market and Strategic Focus on DehydraTECH Integration
- Life Electric Vehicles Holdings Inc. (OTC: LFEV) - Why Trump May Be Unlikely to Stop Public EV Charger Construction
- Lottery.com Inc. (NASDAQ: LTRY) - InvestorNewsBreaks - Lottery.com Inc.'s (NASDAQ: LTRY) Sports.com Achieves Major Milestone in Its Global Expansion
- LQwD Technologies Corp. (TSX.V: LQWD) (OTCQB: LQWDF) - InvestorNewsBreaks - LQWD Technologies Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Announces Record Transaction Growth, No. 1 Ranking on Lightning Terminal
- Massimo Group (NASDAQ: MAMO) - Electric Vehicle Sales are Rebounding in Europe
- McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) - MiningNewsBreaks - McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Begins Construction on Stock Mine Ramp to Lower Costs and Boost Gold Output
- Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) - MIND CURE HEALTH INC. ANNOUNCES CLOSING OF THE FIRST TRANCHE OF LNG ENERGY GROUP'S SUBSCRIPTION RECEIPT FINANCING
- Mydecine Innovations Group Inc. (NEO: MYCO) (FSE: 0NFA) (OTC: MYCOF) - InvestorNewsBreaks - Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Board Approves Issuance of Shares for Debt Settlement
- NanoViricides Inc. (NYSE American: NNVC) - InvestorNewsBreaks - NanoViricides (NYSE American: NNVC) Highlights NV-387 as Broad-Spectrum Antiviral Candidate for COVID and Bird Flu Preparedness
- Newton Golf Company Inc. (NASDAQ: NWTG) - InvestorNewsBreaks - Newton Golf Company Inc. (NASDAQ: NWTG) Signs Miguel Ángel Jiménez Following Victory with Fast Motion Shaft
- NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW) - TinyGemsBreaks - NextPlat Corp. (NASDAQ: NXPL) Announces Passing of CEO Charles M. Fernandez, Appoints Interim Leadership
- Nightfood Holdings Inc. (OTCQB: NGTF) - Smart Hospitality: SkyTech Robots and the Future of U.S. Service Innovation Through AI
- Nowigence Inc. (OTCQB: NOWG) - Nowigence Inc. (NOWG) Starts Trading on OTC
- NRx Pharmaceuticals Inc. (NASDAQ: NRXP) - BioMedNewsBreaks - NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Forms Investor Relations Partnership With astr Partners
- Nutriband Inc. (NASDAQ: NTRB) - BioMedNewsBreaks - Nutriband Inc. (NASDAQ: NTRB) Advances Aversa Fentanyl with Kindeva to Commercial Manufacturing Scale
- Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF) - NetworkNewsBreaks - Nicola Mining Inc. (TSX.V: NIM) (FSE: HLIA) (OTCQB: HUSIF) CEO Highlights Cash Flow and Copper Growth on MiningNewsWire Podcast
- OK Stone Engineering Inc. - InvestorNewsBreaks — OK Stone Engineering Partners with Oren Klaff at Special Investor Event
- Oragenics Inc. (NYSE American: OGEN) - InvestorNewsBreaks - Oragenics Inc. (NYSE American: OGEN) to Spotlight Concussion Candidate at BIO 2025 and Neurotrauma Symposium
- Mullen Automotive Inc. (NASDAQ: MULN) - Trump Signs Measure Overriding EV Mandate, a Blow to Musk and California
- ONAR Holding Corp. (OTCQB: ONAR) - ONAR Holding Corp. (ONAR) Takes the Lead in AI-Driven Marketing as CEO Shares Vision
- PaxMedica Inc. (NASDAQ: PXMD) - Kids with Autism are Less Prone to Severe Injuries Compared to Those with ADHD
- Platinum Group Metals Ltd. (TSX: PTM) (NYSE American: PLG) - Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Advances Waterberg Project Amid Third Straight Year of Platinum Deficits
- Playgon Games Inc. (TSX.V: DEAL) (OTC: PLGNF) - InvestorNewsBreaks - Playgon Games Inc. (TSX.V: DEAL) (OTC: PLGNF) (FSE: 7CR) Receives Recognition for 'Pushing the Boundaries of Live Dealer Gaming'
- Predictive Oncology (NASDAQ: POAI) - InvestorNewsBreaks - Predictive Oncology Inc. (NASDAQ: POAI) Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference
- Processa Pharmaceuticals Inc. (NASDAQ: PCSA) - InvestorNewsBreaks - Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Participate at the H.C. Wainwright 26th Annual Global Investment Conference, ESMO Congress 2024
- Progressive Care Inc. (OTCQB: RXMD) - InvestorNewsBreaks - Progressive Care Inc. (RXMD) Releases Q1 2024 Financial Report Showing Record Revenue
- Prospera Energy Inc. (TSX.V: PEI) (FRA: OF6B) (OTC: GXRFF) - InvestorNewsBreaks - Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) Announces 17% Working Interest Increase in Its Core Heavy Oil Properties
- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) - InvestorNewsBreaks - Quantum BioPharma Ltd. (NASDAQ: QNTM) Advances Brain and Alcohol Health Pipeline, Receives Phase 2 Trial Approval for FSD202
- Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) - InvestorNewsBreaks - Red White & Bloom Brands Inc. (CSE: RWB) Releases Q2 2024 Financial Report, Business Update
- Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) - IEA Review: 2024 Electricity Demand Surge Boosted Both Fossil Fuels and Renewables
- Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) - InvestorNewsBreaks - Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) (FSE: 9RR) Highlights Exploration Strategy and Growth Potential on The Bell2Bell Podcast
- G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) - InvestorNewsBreaks - G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) Files NI 43-101 Technical Report for Oko West Feasibility Study
- REZYFi, Inc. - InvestorNewsBreaks – REZYFi Inc. Using Diversified Approach to Capitalize on Growth in Multiple Verticals
- N2OFF Inc. (NASDAQ: NITO) - InvestorNewsBreaks - N2OFF Inc.'s (NASDAQ: NITO) (FSE: 80W) Subsidiary Enters LOI with Ethiopian Federal Agency to Support Transition to Sustainable Farming Practices
- Software Effective Solutions Corp. (OTC: SFWJ) - InvestorNewsBreaks - Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) Cancels and Swaps Over 88M Shares to Reduce Outstanding Share Count
- SolarBank Corp. (Cboe CA: SUNN) (FSE: GY2) (NASDAQ: SUUN) - California to Fast-Track Largest Project for Battery Energy Storage
- Soligenix Inc. (NASDAQ: SNGX) - Soligenix Inc. (NASDAQ: SNGX) Proprietary Therapy Shows Promise in Treatment of Psoriasis
- Sigyn Therapeutics Inc. (OTCQB: SIGY) - BioMedNewsBreaks - Sigyn Therapeutics Inc. (SIGY) Leveraging Portfolio to Overcome Current Limitations in Healthcare
- Silo Pharma Inc. (OTCQB: SILO) - PsychedelicNewsBreaks - Silo Pharma Inc. (NASDAQ: SILO) Receives USPTO Notice of Allowance for PTSD Treatment Patent
- Silvercorp Metals Inc. (NYSE American: SVM) (TSX: SVM) - InvestorNewsBreaks - Silvercorp Metals Inc. (TSX: SVM) (NYSE American: SVM) Files Updated Resource Estimate for Condor Gold Project in Ecuador
- SuperCom Ltd. (NASDAQ: SPCB) - SuperCom Ltd. (NASDAQ: SPCB) Continues Expansion of National Public Safety EM Contracts
- Siyata Mobile Inc. (NASDAQ: SYTA) - InvestorNewsBreaks - Siyata Mobile Inc. (NASDAQ: SYTA) to Attend Two Upcoming Industry Events
- SOBRsafe Inc. (NASDAQ: SOBR) - TechMediaBreaks - SOBRsafe Inc. (NASDAQ: SOBR) Reports 80.5% Revenue Growth and Improved Margins in Q1 2025
- Solowin Holdings (NASDAQ: SWIN) - Solowin Holdings (NASDAQ: SWIN) Is 'One to Watch'
- Splash Beverage Group Inc. (NYSE American: SBEV) - InvestorNewsBreaks - Splash Beverage Group, Inc. (NYSE American: SBEV) Revises Terms for Western Son Vodka Acquisition
- Standard Lithium Ltd. (NYSE American: SLI) - InvestorNewsBreaks - Standard Lithium Ltd. (NYSE American: SLI) Produces Battery-Grade Lithium Sulfide in Collaboration with Telescope Innovations
- Starco Brands Inc. (OTCQB: STCB) - InvestorNewsBreaks - Starco Brands Inc. (STCB), DoorDash Collaborate in Special Autumn Whipshots Offer
- StorEn Technologies Inc. - InvestorNewsBreaks – StorEn Technologies Inc. Recognized for Bringing Real Innovation to Vanadium Flow Batteries
- Vision Marine Technologies Inc. (NASDAQ: VMAR) - InvestorNewsBreaks - Vision Marine Technologies Inc. (NASDAQ: VMAR) Unveils Market's Most Efficient, Powerful Inboard Electric Motor System
- SenesTech Inc. (NASDAQ: SNES) - InvestorNewsBreaks - SenesTech Inc. (NASDAQ: SNES) Reports 51% Revenue Increase in Q3 2024, Highlights Growth in Evolve Product Line and International Expansion
- Sekur Private Data Ltd. (FRA: GDT0) (CSE: SKUR) (OTCQB: SWISF) - TechMediaBreaks - Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0) Launches D.C.-Based Division to Protect Diplomats from Escalating Cyber Threats
- TAAT Global Alternatives Inc. (CSE: TAAT) (FRANKFURT: 2TP) (OTCQX: TOBAF) - InvestorNewsBreaks - TAAT(TM) Global Alternatives Inc. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) Plans 10-to-One Share Consolidation
- Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF) - InvestorNewsBreaks - Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF) (FSE: 8TA) Names Seasoned Veteran as New Director
- Telomir Pharmaceuticals Inc. (NASDAQ: TELO) - BioMedNewsBreaks - Telomir Pharmaceuticals (NASDAQ: TELO) Reports Preclinical Success for Telomir-1 in Progeria Cell Lines
- Thumzup Media Corp. (NASDAQ: TZUP) - England OKs Teachers' Use of AI While Marking Students' Work
- Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) - InvestorNewsBreaks - Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Presents Positive Phase 3 Data on Fibromyalgia Drug at EULAR 2025
- Torr Metals Inc. (TSX.V: TMET) - Peru Acknowledges the Existence of Widespread Artisanal Copper Mining
- TransCode Therapeutics Inc. (NASDAQ: RNAZ) - InvestorNewsBreaks - TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Appoints RNAi Pioneer Phillip Zamore to Scientific Advisory Board
- Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) - MiningNewsBreaks - Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) Settles $101K Debt with Share Issuance Including Insider Participation
- Turbo Energy S.A. (NASDAQ: TURB) - InvestorNewsBreaks - Turbo Energy S.A. (NASDAQ: TURB) Shareholders Approve Key Proposals at Extraordinary General Meeting
- Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) - MiningNewsBreaks - Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Closes Oversubscribed Private Placement for Strategic Metals Complex Development
- Uranium Energy Corp. (NYSE American: UEC) - InvestorNewsBreaks - Uranium Energy Corp. (NYSE American: UEC) Ramps Up U.S. Production as Nuclear Demand Surges
- VistaGen Therapeutics Inc. (NASDAQ: VTGN) - InvestorNewsBreaks - Vistagen Therapeutics Inc. (NASDAQ: VTGN) Announces Joint Ceremony to Ring Nasdaq Closing Bell in Honor of World Mental Health Day
- Vivakor Inc. (NASDAQ: VIVK) - InvestorNewsBreaks - Why Vivakor Inc. (NASDAQ: VIVK) Is 'One to Watch'
- Vivos Therapeutics Inc. (NASDAQ: VVOS) - InvestorNewsBreaks - Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces AMA Issues CPT Codes, Coverage for Vivos CARE Oral Medical Devices
- Datavault AI Inc. (NASDAQ: DVLT) - InvestorNewsBreaks - Datavault AI Inc. (NASDAQ: DVLT) and GFT Rewards Partner to Deliver ADIO(R)-Powered Web3 Mobile Incentives
- Wheaton Precious Metals Corp. (TSX: WPM) (NYSE: WPM) - InvestorNewsBreaks - Wheaton Precious Metals Corp. (NYSE: WPM) (TSX: WPM) Releases 2024 Sustainability and Climate Change Reports Highlighting ESG Progress
- Wrap Technologies Inc. (NASDAQ: WRAP) - Wrap Technologies, Inc. Bolsters BolaWrap® 150 Deployments, Promoting Safer Communities Nationwide
- Zoned Properties Inc. (ZDPY) - InvestorNewsBreaks - Zoned Properties Inc. (ZDPY) Releases Q2 2024 Financial Results, Operations Report
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- 180 Life Sciences Corp. (NASDAQ: ATNF) - 180 Life Sciences Corp. Announces Notice of Allowance for U.S. Patent Covering Novel Method to Prevent or Reduce Post-Operative Cognitive Dysfunction
- Adageis - Adageis Allows Healthcare Providers Maximum Value-Based Care Revenue with Simplicity and Visibility
- Aditxt Inc. (NASDAQ: ADTX) - BioMedNewsBreaks - Aditxt Inc. (NASDAQ: ADTX) Terminates Acquisition Agreement with Appili Therapeutics
- Amesite Inc. (NASDAQ: AMST) - Amesite Announces Successful Launch of New, Higher-Priced Tier of Service in Response to B2B Demand
- Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) - Appia Announces That Stephen Burega is Leaving the Company
- Annovis Bio Inc. (NYSE: ANVS) - BioMedNewsBreaks - Annovis Bio Inc. (NYSE: ANVS) to Host Webcast With CEO to Share Updates on Alzheimer's and Parkinson's Programs
- Astiva Health - More American Doctors are Relocating to Canada, Citing Federal Government Issues
- Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF) - Arizona Metals Intersects 34.8 m @ 11.3 g/t AuEq in Kay2 Zone
- Astrotech Corp. (NASDAQ: ASTC) - 1st Detect Unveils Enhanced TRACER 1000 Narcotics Trace Detector Intended to Combat Synthetic Opiates and Novel Psychoactive Substances
- Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) - Copper Supply Disparities Grow as More Shipments Head to the US
- Augmedix Inc. (NASDAQ: AUGX) - Augmedix Partners with Google Cloud to Bring Medically-Tuned AI Technology to Ambient Documentation
- Beeline Holdings Inc. (NASDAQ: BLNE) - AINewsBreaks - Beeline Holdings, Inc. (NASDAQ: BLNE) Unveils Blockchain-Linked Equity Solution to Bypass Interest Rates
- BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) - InvestorNewsBreaks - BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Releases Shareholder Update with Corporate, Operational Highlights
- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) - BioMedNewsBreaks - Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Receives Italian Clearance for Option to Acquire Biotech Firm Pincell
- Bravo Multinational Inc. (OTC: BRVO) - InvestorNewsBreaks - Bravo Multinational Inc. (OTC: BRVO) Unveils First Charitable Mobile Service
- BioNxt Solutions Inc. (CSE: BNXT) (OTCQB: BNXTF) (FSE: 4XT) - BioNxt Solutions Reports Expanded Patent Protection from the Eurasian Patent Organization
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) - Blue Hat Interactive Entertainment Technology 2024 Financial Results Report: Total Assets Surge by 53%
- Btab Ecommerce Group Inc. (OTC: BBTT) - Integrated Wellness Acquisition Corp. and Btab Ecommerce Group, Inc. Announce Filing of Draft Registration Statement on Form S-4 with the SEC
- Brera Holdings PLC (NASDAQ: BREA) - NetworkNewsBreaks - Brera Holdings PLC (NASDAQ: BREA) Forms Strategic Alliance with Toronto Blizzard to Develop Global Soccer Talent Pipeline
- Calidi Biotherapeutics Inc. (NYSE American: CLDI) - TinyGemsBreaks - Calidi Biotherapeutics Inc. (NYSE American: CLDI) Taps Biotech Veteran to Lead Next Phase of Growth
- Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) - Canada Nickel Secures US$20 Million Bridge Loan Facilitated by BT Capital and Provides Corporate Update
- CISO Global, Inc. (NASDAQ: CISO) - CISO Global brings AI to $50 Billion Insurance Market with Cyber Assurance Group Strategic Partnership to Deliver Innovative Cyber Technology and Insurance Solutions
- Clene Inc. (NASDAQ: CLNN) - Study Finds Kids with MS Biologically Age Faster Than Those Without It
- CNS Pharmaceuticals Inc. (NASDAQ: CNSP) - BioMedNewsBreaks - CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present Promising Glioblastoma Data at Brain Tumor Biotech Summit
- Correlate Energy Corp. (OTCQB: CIPI) - GreenEnergyBreaks - Correlate Energy Corp. (CIPI) Facilitating Global Transition Toward Solar
- Coyuchi Inc. - InvestorNewsBreaks – Coyuchi Inc. Pushing Organic Textile Market Forward Through Its Circular Initiatives
- Cub Crafters Inc. - InvestorNewsBreaks – CubCrafters Inc. Eyes Increase in Stock Price
- Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) - InvestorNewsBreaks - Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Highlights Progress on Phase 3 Psychedelic Therapeutics Program
- DarioHealth Corp. (NASDAQ: DRIO) - Dario's Digital Health Solution Demonstrates Effectiveness in New Research Examining Flu Vaccination Awareness in High-Risk Populations
- Diamond Lake Minerals Inc. (OTC: DLMI) - Diamond Lake Minerals Launches Advanced Materials & IP Division and Files Inaugural Provisional Patent for Physics-Informed Valuation Technology
- Data443 Risk Mitigation Inc. (OTC: ATDS) - Data443 Completes Operational Expense Rationalization
- D-Wave Quantum Inc. (NYSE: QBTS) - TechMediaBreaks - D-Wave Quantum Inc. (NYSE: QBTS) Signs MOU to Advance Quantum Computing in South Korea
- ECGI Holdings Inc. (OTC: ECGI) - InvestorNewsBreaks - ECGI Holdings Inc. (OTC: ECGI) Invests in AI-Driven Fantasy Sports Platform Payday Fantasy
- Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) - Eloro Resources Announces Closing of $2.5 Million Non-Brokered Private Placement
- Emperor Metals Inc. (CSE: AUOZ) (FRA:9NH) (OTCQB: EMAUF) - InvestorNewsBreaks - Emperor Metals Inc. (CSE: AUOZ) (OTCQB: EMAUF) (FRA:9NH) to Attend Tier I Mining Conference in Québec City
- Energy and Water Development Corp. (OTCQB: EAWD) - Data Officers and the Crucial Role They Play in ESG Accountability
- Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) - BillionDollarBreaks - Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Elects Board, Names Bruce Hansen as New Chair
- EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) - EverGen Infrastructure Reports Q4 & Year End 2024 Results
- ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) - RockBreaks - ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Launches $3.3 Million Private Placement to Advance Montauban Project
- Exro Technologies Inc. (TSX: EXRO) (OTCQB: EXROF) - Exro Technologies Responds to Market Activity
- FingerMotion Inc. (NASDAQ: FNGR) - ChineseNewsBreaks - FingerMotion Inc. (NASDAQ: FNGR) Subsidiary JiuGe Forms Strategic Alliance for Emergency Response Vehicles
- First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) - InvestorNewsBreaks - First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) Successfully Road-Tests Thermoelectric Generator Radiator
- Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) - RockBreaks - Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Expands Gochager Lake Property, Postpones Field Program Due to Saskatchewan Wildfires
- Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) - BillionDollarBreaks - Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Elects Board, Names Bruce Hansen as New Chair
- FE Battery Metals Corp. (CSE: FE) (OTCQB: FEMFF) - InvestorNewsBreaks - FE Battery Metals Corp. (CSE: FE) (OTCQB: FEMFF) (WKN: A2JC89) Announces Proposed $1M Non-Brokered Private Placement
- Flora Growth Corp. (NASDAQ: FLGC) - InvestorNewsBreaks - Flora Growth Corp. (NASDAQ: FLGC) Closes $3.6M Registered Direct
- Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) - InvestorNewsBreaks - Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) Secures Permit for Athabasca Basin Uranium Exploration
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) - InvestorNewsBreaks - Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), BuilderX Partner to Integrate Advanced 3D Perception Technology into Heavy Machinery
- Fresh2 Group Ltd. (NASDAQ: FRES) - Appointment of New Independent Director
- Freight Technologies Inc. (NASDAQ: FRGT) - TechMediaBreaks - Freight Technologies Inc. (NASDAQ: FRGT) Moves to Advance Digital Asset Strategy
- Gaxos.ai Inc. (NASDAQ: GXAI) - TechMediaBreaks - Gaxos.ai Inc. (NASDAQ: GXAI) Launches UnGPT.ai to Transform AI-Generated Text into Humanlike Content
- GEMXX Corp. (OTC: GEMZ) - The Oil, Gas Sector is Already Feeling the Effects of the Israel-Iran Conflict
- GeoSolar Technologies Inc. - QualityStocksNewsBreaks – GeoSolar Technologies Inc. Taking Part in Shift Toward a Greener Future
- Global Compliance Applications Corp. (CSE: APP) (OTCQB: FUAPF) - InvestorNewsBreaks - Global Compliance Applications Corp. (CSE: APP) (OTC: FUAPF) (FSE: 2FA), EMTRI Corp. Scale Services in California's Booming Cannabis Market
- GivBux Inc. (OTC: GBUX) - TechMediaBreaks - GivBux Inc. (OTC: GBUX) Finalizes Deal to Acquire Charter House, Refocuses on Gold-Backed Fintech Expansion
- Golden Matrix Group Inc. (NASDAQ: GMGI) - InvestorNewsBreaks - Golden Matrix Group Inc. (NASDAQ: GMGI) CEO to Present at the Upcoming 17th Annual LD Micro Main Event
- SportLync Inc. - SportLync Outlines 2025 Roadmap, with Expanded Sports Offerings and Enhanced User Experiences
- Greenwave Technology Solutions Inc. (NASDAQ: GWAV) - TechMediaBreaks - Greenwave Technology Solutions Inc. (NASDAQ: GWAV) Sees Margin Growth as Scrap Steel Prices Surge
- RYVYL Inc. (NASDAQ: RVYL) - InvestorNewsBreaks - RYVYL Inc. (NASDAQ: RVYL) to Participate at Upcoming LD Micro Main Event XVII
- HeartBeam Inc. (NASDAQ: BEAT) - InvestorNewsBreaks - HeartBeam Inc. (NASDAQ: BEAT) Secures Two New Patents Advancing 3D ECG and Cardiac Monitoring Technology
- HealthLynked Corp. (OTCQB: HLYK) - BioMedNewsBreaks - HealthLynked Corp. (HLYK) Launches Upgrade to Empower Patients, Drive Better Outcomes
- Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTD) (FRA: 7HIA.F) - InvestorNewsBreaks - Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F) CEO Featured in Latest Episode of MarketGems Podcast
- Horizon Fintex | Upstream - InvestorNewsBreaks – Upstream Enhances KYC Process to Streamline User Experience
- IGC Pharma Inc. (NYSE American: IGC) - InvestorNewsBreaks - IGC Pharma Inc. (NYSE American: IGC) Advances IGC-AD1 Research to Potentially Deliver 'Breakthrough Treatment' in Alzheimer's Disease
- Infobird Co., Ltd (NASDAQ: IFBD) - InvestorNewsBreaks - Infobird Co. Ltd. (NASDAQ: IFBD) Announces Delayed Effective Date of Reverse Split
- InMed Pharmaceuticals Inc. (NASDAQ: INM) - InvestorNewsBreaks - InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Fiscal 2024 Financial Results, Provides Business Update
- Intelligent Bio Solutions Inc. (NASDAQ: INBS) - BioMedNewsBreaks - Intelligent Bio Solutions Inc. (NASDAQ: INBS) to Deploy Fingerprint Drug Testing System Across MWS Sites in Australia
- Safety Shot Inc. (NASDAQ: SHOT) - InvestorNewsBreaks - Safety Shot (NASDAQ: SHOT) Launches Rebrand Featuring New Name, New Look, New Packaging
- BlockQuarry Corp. (OTC: BLQC) - InvestorNewsBreaks - BlockQuarry Corp. (BLQC) Completes 'Key Steps' in Long-Term Vision to Strengthen Position as an Innovator in Healthcare Solutions
- Kairos Pharma Ltd. (NYSE American: KAPA) - InvestorNewsBreaks - Kairos Pharma Ltd. (NYSE American: KAPA) Highlights Positive Preclinical Data for KROS101 at ASCO 2025
- Knightscope (NASDAQ: KSCP) - InvestorNewsBreaks - Knightscope, Inc. (NASDAQ: KSCP) Secures Over $1 Million in Contracts Including New ASR and ECD Deployments
- Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) - RockBreaks - Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Gains BLM Approval for Expanded Drilling at Santa Fe Mine
- Lantern Pharma Inc. (NASDAQ: LTRN) - InvestorNewsBreaks - Lantern Pharma Inc. (NASDAQ: LTRN) Reports Complete Response in Advanced NSCLC Patient in HARMONIC(TM) Trial
- Laredo Oil Inc. (OTC: LRDC) - InvestorNewsBreaks - Laredo Oil Inc. (LRDC) Announces Entry into Common Stock Purchase Agreements with Gross Proceeds of $750K
- Longeveron Inc. (NASDAQ: LGVN) - InvestorNewsBreaks - Longeveron Inc. (NASDAQ: LGVN) to Present 'Important' Lomecel-B(TM) Data at the 17th Clinical Trials on Alzheimer's Disease Conference
- Lexaria Bioscience Corp. (NASDAQ: LEXX) - InvestorNewsBreaks - Lexaria Bioscience Corp. (NASDAQ: LEXX) Highlights Expanding Opportunities in GLP-1 Drug Market and Strategic Focus on DehydraTECH Integration
- Life Electric Vehicles Holdings Inc. (OTC: LFEV) - Why Trump May Be Unlikely to Stop Public EV Charger Construction
- Lottery.com Inc. (NASDAQ: LTRY) - InvestorNewsBreaks - Lottery.com Inc.'s (NASDAQ: LTRY) Sports.com Achieves Major Milestone in Its Global Expansion
- LQwD Technologies Corp. (TSX.V: LQWD) (OTCQB: LQWDF) - InvestorNewsBreaks - LQWD Technologies Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Announces Record Transaction Growth, No. 1 Ranking on Lightning Terminal
- Massimo Group (NASDAQ: MAMO) - Electric Vehicle Sales are Rebounding in Europe
- McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) - MiningNewsBreaks - McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Begins Construction on Stock Mine Ramp to Lower Costs and Boost Gold Output
- Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) - MIND CURE HEALTH INC. ANNOUNCES CLOSING OF THE FIRST TRANCHE OF LNG ENERGY GROUP'S SUBSCRIPTION RECEIPT FINANCING
- Mydecine Innovations Group Inc. (NEO: MYCO) (FSE: 0NFA) (OTC: MYCOF) - InvestorNewsBreaks - Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Board Approves Issuance of Shares for Debt Settlement
- NanoViricides Inc. (NYSE American: NNVC) - InvestorNewsBreaks - NanoViricides (NYSE American: NNVC) Highlights NV-387 as Broad-Spectrum Antiviral Candidate for COVID and Bird Flu Preparedness
- Newton Golf Company Inc. (NASDAQ: NWTG) - InvestorNewsBreaks - Newton Golf Company Inc. (NASDAQ: NWTG) Signs Miguel Ángel Jiménez Following Victory with Fast Motion Shaft
- NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW) - TinyGemsBreaks - NextPlat Corp. (NASDAQ: NXPL) Announces Passing of CEO Charles M. Fernandez, Appoints Interim Leadership
- Nightfood Holdings Inc. (OTCQB: NGTF) - Smart Hospitality: SkyTech Robots and the Future of U.S. Service Innovation Through AI
- Nowigence Inc. (OTCQB: NOWG) - Nowigence Inc. (NOWG) Starts Trading on OTC
- NRx Pharmaceuticals Inc. (NASDAQ: NRXP) - BioMedNewsBreaks - NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Forms Investor Relations Partnership With astr Partners
- Nutriband Inc. (NASDAQ: NTRB) - BioMedNewsBreaks - Nutriband Inc. (NASDAQ: NTRB) Advances Aversa Fentanyl with Kindeva to Commercial Manufacturing Scale
- Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF) - NetworkNewsBreaks - Nicola Mining Inc. (TSX.V: NIM) (FSE: HLIA) (OTCQB: HUSIF) CEO Highlights Cash Flow and Copper Growth on MiningNewsWire Podcast
- OK Stone Engineering Inc. - InvestorNewsBreaks — OK Stone Engineering Partners with Oren Klaff at Special Investor Event
- Oragenics Inc. (NYSE American: OGEN) - InvestorNewsBreaks - Oragenics Inc. (NYSE American: OGEN) to Spotlight Concussion Candidate at BIO 2025 and Neurotrauma Symposium
- Mullen Automotive Inc. (NASDAQ: MULN) - Trump Signs Measure Overriding EV Mandate, a Blow to Musk and California
- ONAR Holding Corp. (OTCQB: ONAR) - ONAR Holding Corp. (ONAR) Takes the Lead in AI-Driven Marketing as CEO Shares Vision
- PaxMedica Inc. (NASDAQ: PXMD) - Kids with Autism are Less Prone to Severe Injuries Compared to Those with ADHD
- Platinum Group Metals Ltd. (TSX: PTM) (NYSE American: PLG) - Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Advances Waterberg Project Amid Third Straight Year of Platinum Deficits
- Playgon Games Inc. (TSX.V: DEAL) (OTC: PLGNF) - InvestorNewsBreaks - Playgon Games Inc. (TSX.V: DEAL) (OTC: PLGNF) (FSE: 7CR) Receives Recognition for 'Pushing the Boundaries of Live Dealer Gaming'
- Predictive Oncology (NASDAQ: POAI) - InvestorNewsBreaks - Predictive Oncology Inc. (NASDAQ: POAI) Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference
- Processa Pharmaceuticals Inc. (NASDAQ: PCSA) - InvestorNewsBreaks - Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Participate at the H.C. Wainwright 26th Annual Global Investment Conference, ESMO Congress 2024
- Progressive Care Inc. (OTCQB: RXMD) - InvestorNewsBreaks - Progressive Care Inc. (RXMD) Releases Q1 2024 Financial Report Showing Record Revenue
- Prospera Energy Inc. (TSX.V: PEI) (FRA: OF6B) (OTC: GXRFF) - InvestorNewsBreaks - Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) Announces 17% Working Interest Increase in Its Core Heavy Oil Properties
- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) - InvestorNewsBreaks - Quantum BioPharma Ltd. (NASDAQ: QNTM) Advances Brain and Alcohol Health Pipeline, Receives Phase 2 Trial Approval for FSD202
- Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) - InvestorNewsBreaks - Red White & Bloom Brands Inc. (CSE: RWB) Releases Q2 2024 Financial Report, Business Update
- Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) - IEA Review: 2024 Electricity Demand Surge Boosted Both Fossil Fuels and Renewables
- Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) - InvestorNewsBreaks - Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) (FSE: 9RR) Highlights Exploration Strategy and Growth Potential on The Bell2Bell Podcast
- G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) - InvestorNewsBreaks - G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) Files NI 43-101 Technical Report for Oko West Feasibility Study
- REZYFi, Inc. - InvestorNewsBreaks – REZYFi Inc. Using Diversified Approach to Capitalize on Growth in Multiple Verticals
- N2OFF Inc. (NASDAQ: NITO) - InvestorNewsBreaks - N2OFF Inc.'s (NASDAQ: NITO) (FSE: 80W) Subsidiary Enters LOI with Ethiopian Federal Agency to Support Transition to Sustainable Farming Practices
- Software Effective Solutions Corp. (OTC: SFWJ) - InvestorNewsBreaks - Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) Cancels and Swaps Over 88M Shares to Reduce Outstanding Share Count
- SolarBank Corp. (Cboe CA: SUNN) (FSE: GY2) (NASDAQ: SUUN) - California to Fast-Track Largest Project for Battery Energy Storage
- Soligenix Inc. (NASDAQ: SNGX) - Soligenix Inc. (NASDAQ: SNGX) Proprietary Therapy Shows Promise in Treatment of Psoriasis
- Sigyn Therapeutics Inc. (OTCQB: SIGY) - BioMedNewsBreaks - Sigyn Therapeutics Inc. (SIGY) Leveraging Portfolio to Overcome Current Limitations in Healthcare
- Silo Pharma Inc. (OTCQB: SILO) - PsychedelicNewsBreaks - Silo Pharma Inc. (NASDAQ: SILO) Receives USPTO Notice of Allowance for PTSD Treatment Patent
- Silvercorp Metals Inc. (NYSE American: SVM) (TSX: SVM) - InvestorNewsBreaks - Silvercorp Metals Inc. (TSX: SVM) (NYSE American: SVM) Files Updated Resource Estimate for Condor Gold Project in Ecuador
- SuperCom Ltd. (NASDAQ: SPCB) - SuperCom Ltd. (NASDAQ: SPCB) Continues Expansion of National Public Safety EM Contracts
- Siyata Mobile Inc. (NASDAQ: SYTA) - InvestorNewsBreaks - Siyata Mobile Inc. (NASDAQ: SYTA) to Attend Two Upcoming Industry Events
- SOBRsafe Inc. (NASDAQ: SOBR) - TechMediaBreaks - SOBRsafe Inc. (NASDAQ: SOBR) Reports 80.5% Revenue Growth and Improved Margins in Q1 2025
- Solowin Holdings (NASDAQ: SWIN) - Solowin Holdings (NASDAQ: SWIN) Is 'One to Watch'
- Splash Beverage Group Inc. (NYSE American: SBEV) - InvestorNewsBreaks - Splash Beverage Group, Inc. (NYSE American: SBEV) Revises Terms for Western Son Vodka Acquisition
- Standard Lithium Ltd. (NYSE American: SLI) - InvestorNewsBreaks - Standard Lithium Ltd. (NYSE American: SLI) Produces Battery-Grade Lithium Sulfide in Collaboration with Telescope Innovations
- Starco Brands Inc. (OTCQB: STCB) - InvestorNewsBreaks - Starco Brands Inc. (STCB), DoorDash Collaborate in Special Autumn Whipshots Offer
- StorEn Technologies Inc. - InvestorNewsBreaks – StorEn Technologies Inc. Recognized for Bringing Real Innovation to Vanadium Flow Batteries
- Vision Marine Technologies Inc. (NASDAQ: VMAR) - InvestorNewsBreaks - Vision Marine Technologies Inc. (NASDAQ: VMAR) Unveils Market's Most Efficient, Powerful Inboard Electric Motor System
- SenesTech Inc. (NASDAQ: SNES) - InvestorNewsBreaks - SenesTech Inc. (NASDAQ: SNES) Reports 51% Revenue Increase in Q3 2024, Highlights Growth in Evolve Product Line and International Expansion
- Sekur Private Data Ltd. (FRA: GDT0) (CSE: SKUR) (OTCQB: SWISF) - TechMediaBreaks - Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0) Launches D.C.-Based Division to Protect Diplomats from Escalating Cyber Threats
- TAAT Global Alternatives Inc. (CSE: TAAT) (FRANKFURT: 2TP) (OTCQX: TOBAF) - InvestorNewsBreaks - TAAT(TM) Global Alternatives Inc. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) Plans 10-to-One Share Consolidation
- Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF) - InvestorNewsBreaks - Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF) (FSE: 8TA) Names Seasoned Veteran as New Director
- Telomir Pharmaceuticals Inc. (NASDAQ: TELO) - BioMedNewsBreaks - Telomir Pharmaceuticals (NASDAQ: TELO) Reports Preclinical Success for Telomir-1 in Progeria Cell Lines
- Thumzup Media Corp. (NASDAQ: TZUP) - England OKs Teachers' Use of AI While Marking Students' Work
- Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) - InvestorNewsBreaks - Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Presents Positive Phase 3 Data on Fibromyalgia Drug at EULAR 2025
- Torr Metals Inc. (TSX.V: TMET) - Peru Acknowledges the Existence of Widespread Artisanal Copper Mining
- TransCode Therapeutics Inc. (NASDAQ: RNAZ) - InvestorNewsBreaks - TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Appoints RNAi Pioneer Phillip Zamore to Scientific Advisory Board
- Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) - MiningNewsBreaks - Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) Settles $101K Debt with Share Issuance Including Insider Participation
- Turbo Energy S.A. (NASDAQ: TURB) - InvestorNewsBreaks - Turbo Energy S.A. (NASDAQ: TURB) Shareholders Approve Key Proposals at Extraordinary General Meeting
- Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) - MiningNewsBreaks - Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Closes Oversubscribed Private Placement for Strategic Metals Complex Development
- Uranium Energy Corp. (NYSE American: UEC) - InvestorNewsBreaks - Uranium Energy Corp. (NYSE American: UEC) Ramps Up U.S. Production as Nuclear Demand Surges
- VistaGen Therapeutics Inc. (NASDAQ: VTGN) - InvestorNewsBreaks - Vistagen Therapeutics Inc. (NASDAQ: VTGN) Announces Joint Ceremony to Ring Nasdaq Closing Bell in Honor of World Mental Health Day
- Vivakor Inc. (NASDAQ: VIVK) - InvestorNewsBreaks - Why Vivakor Inc. (NASDAQ: VIVK) Is 'One to Watch'
- Vivos Therapeutics Inc. (NASDAQ: VVOS) - InvestorNewsBreaks - Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces AMA Issues CPT Codes, Coverage for Vivos CARE Oral Medical Devices
- Datavault AI Inc. (NASDAQ: DVLT) - InvestorNewsBreaks - Datavault AI Inc. (NASDAQ: DVLT) and GFT Rewards Partner to Deliver ADIO(R)-Powered Web3 Mobile Incentives
- Wheaton Precious Metals Corp. (TSX: WPM) (NYSE: WPM) - InvestorNewsBreaks - Wheaton Precious Metals Corp. (NYSE: WPM) (TSX: WPM) Releases 2024 Sustainability and Climate Change Reports Highlighting ESG Progress
- Wrap Technologies Inc. (NASDAQ: WRAP) - Wrap Technologies, Inc. Bolsters BolaWrap® 150 Deployments, Promoting Safer Communities Nationwide
- Zoned Properties Inc. (ZDPY) - InvestorNewsBreaks - Zoned Properties Inc. (ZDPY) Releases Q2 2024 Financial Results, Operations Report
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.